Table of Contents

UNITED STATES

SECURITIES AND EXCHANGECOMMISSION

Washington,Washington, D.C. 20549


FORM 10-Q


(MarkOne)

xQUARTERLY REPORT PURSUANTTOSECTION13 OR15(d) OFTHESECURITIES EXCHANGE ACT OF 1934

For the quarterly periodended September 30, 2008


March 31, 2020

or


oTRANSITION REPORT PURSUANTTOSECTION13 OR15(d)OFTHESECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ ____________________  to __________


________________________

Commission File Number file : 0-27569


NATURAL NUTRITION, INC.number:
0001070050

AppTechCorp.

(Exact name of registrant asspecified inits charter)


NevadaWy
oming
65-0847995
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification
Number)

5876Owens Ave. Suite 100

Carlsbad, California 92008

(Address ofPrincipal Executive Offices &Zip Code)

(760) 707-5959

(Registrant’s telephonenumber,including area code)

Securities registered pursuant to Section12(b) of theAct:

Titleof each class(IRS Employer Identification No.)Trading Symbol(s)Nameof each exchange on which registered
   
109 North Post Oak Lane, Suite 422Common Stock,$0.001
par value perHouston, TX 77024share
(Address of principal executive offices)
    APCX
(713) 621-2737OTC
(Registrant’s telephone number, including area code)
Pink Open Market

Securities registered pursuant to Section 12(g) of theAct:

None

Indicate by checkmark whetherthe registrant (1)has filed all reportsrequired to befiled by Section 13 or 15(d) ofthe SecuritiesExchange Act of1934during the preceding 12months (orfor such shorter periodthat the Securities Exchange Actregistrant was required tofile such reports),and (2)has been subject tosuch filing requirementsfor the past 90days. Yes  ☐  No  ☒

Indicateby checkmark whether the registranthas submitted electronically every Interactive DataFile required to besubmitted pursuant toRule 405 of 1934 RegulationS-T(§ 232.405 ofthis chapter)duringthe preceding 12months (orfor such shorter period that the registrant was required to filesubmit such reports), and (2) has been subject to such filing requirements for the past 90 days. files). Yes  x☒  No  

oIndicate


Indicate by checkmark whether the registrant is alargeacceleratedfiler, an acceleratedfiler,a non-acceleratedfiler, asmaller reportingcompany, or a small reportingemerginggrowth company. Seethe definitions of “large accelerated filer,” “accelerated ” acceleratedfiler” and “small“smaller reporting company,”and“emerging growth company”inRule12b-2 ofthe Exchange Act.

Largeacceleratedfiler ☐Acceleratedfiler☐ 
Non-accelerated filer ☐Smallerreporting company☒ 
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Large accelerated filer o
Accelerated filer o
Non-accelerated filer o (Do not check if a small reporting company)
Smaller reporting company x

  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o☐  No  x


The number

As of May 14,2020, the latest practicable date, the registrant had 86,538,325 shares outstanding of our common stock at November 7, 2008 was 64,576,333.(par value 0.001)


Transitional Small Business Disclosure Format (check one): Yes: o No: x

NATURAL NUTRITION, INC.
FORM

AppTech Corp.

Form 10-Q



INDEX

Table of Contents

Page
Page
Number
Part I
 
PART I - FINANCIAL INFORMATIONSpecial Note Regarding Forward-Looking Statements and Projections2
Item 1.Financial Statements
Condensed Consolidated Balance Sheets as of September 30, 2008 (Unaudited) and December 31, 2007 (Audited)3
Condensed Consolidated Statements of Operations for the nine months ended September 30, 2008 and 2007 (Unaudited) (unaudited)4
Condensed Consolidated Balance Sheet as of March 31, 2020 and December 31, 20195
Condensed Consolidated Statements of Operations for the three months ended September 30, 2008March 31, 2020 and 2007 (Unaudited)201956
Condensed Consolidated Statements of Stockholder’s Deficit for the three months ended March 31, 2020 and 20197
Legal Proceedings Condensed Consolidated Statements of Cash Flows for the ninethree  months ended September 30, 2008March 31, 2020 and 2007 (Unaudited)201968
Notes to Condensedthe Unaudited Consolidated Financial Statements (Unaudited)7-149
Item 2. Management'sLegal Proceedings Management’s Discussion and Analysis or Plan of Operation15-19
Item 4T. ControlsFinancial Condition and ProceduresResults of Operations20
Item 3.Legal Quantitative and Qualitative Disclosures about Market Risk24
PARTItem 4.Controls and Procedures24
Part II - OTHER INFORMATION
Item 1.Legal Proceedings2125
Item 1A.Risk Factors2125
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds2125
Item 3.Defaults Upon Senior Securities2126
Item 4. Submission of Matters to a Vote of Security Holders21Mine Safety Disclosures26
Item 5.Other Information2126
Item 6. Exhibits21
SIGNATURESExhibits22

2

PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
26
 Signatures28

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND PROJECTIONS

Various statementsin this Quarterlyon Form 10-Q of AppTech Corp.(we, our, AppTech orthe Company)are “forward-looking statements”within themeaningof thePrivate Securities Litigation ReformActof 1995. Forward-lookingstatements involvesubstantialrisksand uncertainties. All statements, otherthanstatements ofhistorical facts, included in this report regardingourstrategy,future operations,future financial position, future revenues, projectedcosts, prospects, plansandobjectives ofmanagement are forward-lookingstatements.These statements are subject torisks and uncertainties and are based oninformation currently available toour management. Wordssuchas“anticipate,”“believe,”“estimate,”“expect,”“intend,” “may,” “plan,”“contemplates,” “predict,” “project,”“target,” “likely,” “potential,”“continue,” “ongoing,”“will,”“would,” “should,” “could,”orthe negative ofthese terms andsimilar expressions orwords, identify forward-lookingstatements.The events andcircumstances reflected inourforward-looking statements maynotoccurand actual resultscould differmaterially fromthoseprojected inour forward-looking statements. Meaningful factorsthat could causeactualresults todifferinclude:

NATURAL NUTRITION, INC. AND SUBSIDIARIESuncertaintyassociatedwith anticipatedlaunch ofour Secure TextPayment System;
CONDENSED CONSOLIDATED BALANCE SHEETSdependence on third-partychannel andreferral partners,who comprise asignificant portion ofour sales force, for gaining new clients;
thepossibility thatwe mayfail to sustain the listing standardsrequired to up-list tothe OTCQBMarket, and the possibility that evenifwe do sustain potentialcompliance,we may again fail to complywith the OTCQBlisting standardsinthe future;
aslowdown or reductionin oursales indue to a reductioninend user demand, unanticipatedcompetition, regulatory issues, orother unexpected circumstances;



  September 30, 2008 December 31, 2007 
  (Unaudited) (Audited) 
ASSETS
     
CURRENT ASSETS
     
Cash $1,677,987 $1,923,429 
Trade accounts receivable-net of $13,726 and $35,307 allowance for doubtful accounts  2,386,331  1,860,411 
Notes receivable - net of allowance of $929,973 and $-0-  280,561  1,203,405 
Inventory-net of allowance of $48,897 and $108,400  1,945,938  1,770,595 
Investment in marketable securities  50,000  1,692,856 
Deferred finance costs  111,849  134,977 
Prepaids, accrued interest and other accounts receivable  472,656  287,984 
Total current assets  6,925,322  8,873,657 
NONCURRENT ASSETS
       
Fixed assets, net  1,253,707  1,361,530 
Intellectual property  3,558,464  4,294,719 
Goodwill  9,282,970  9,900,198 
Total noncurrent assets  14,095,141  15,556,447 
TOTAL ASSETS
 $21,020,463 $24,430,104 
LIABILITIES AND SHAREHOLDERS' DEFICIT
       
CURRENT LIABILITIES
       
Accounts payable, accrued liabilities and other current liabilities $1,817,051 $1,382,476 
Accrued interest payable  374,254  275,503 
Current portion of note payable - net of discount of $244,625 and $318,501  1,164,885  1,210,539 
Deferred taxes payable  2,527,725  2,419,767 
Total current liabilities  5,883,915  5,288,285 
NONCURRENT LIABILITIES
       
Convertible debenture payable--net of discount of $141,793 and $167,777  15,018,104  15,233,120 
Convertible note payable--net of discount of $1,367,932 and $1,617,208  6,515,452  6,146,646 
Derivative liabilities  5,805,954  12,184,777 
Deferred taxes payable  -  649,226 
Capital lease obligations  101,296  148,902 
Accrued interest payable  2,057,487  1,483,384 
Total liabilities  35,382,208  41,134,340 
        
COMMITMENTS AND CONTINGENCIES
       
        
SHAREHOLDERS' DEFICIT
       
Preferred stock, $.01 par value; 10,000,000 shares authorized       
Preferred stock Series A Convertible $0.01 par value;       
100,000 shares authorized, 19,643 and 94,443 shares issued and outstanding and no       
liquidation or redemption value  196  944 
Preferred stock Series B Convertible $0.001 par value;       
100,000 shares authorized, 71,455 and -0- shares issued and outstanding and no       
liquidation or redemption value  72  - 
Common stock, par value $0.001; 10,000,000,000 shares       
authorized; 69,645,958 and 37,196,387 issued and outstanding  69,646  29,757 
Additional paid-in capital  737,899  497,074 
Retained deficit  (15,387,024) (18,511,466)
Accumulated other comprehensive income, foreign currency translation adjustment  217,466  1,279,455 
Total shareholders' deficit  (14,361,745) (16,704,236)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT
 $21,020,463 $24,430,104 
See accompanying uncertainty regardingour ability toachieve profitabilityand positive cash flow throughthe commercialization of ourSecure TextPayment System inthe U.S.and other regions of theworld whereweintend tosell the product;
dependence on third-party payment processors tofacilitate ourmerchant services capabilities;
general economicuncertainty associatedwith the Covid-19 pandemic;
the adverse effects of COVID-19,and itsunpredictable duration, in regionswherewehave customers, employeesand distributors;
the adverse effects of COVID-19 on processing volumes resulting from (a) limitations on in-person access to our merchants’ businesses or (b) the unwillingness of to visit our merchants’ businesses;
the possibilitythat the economicimpact ofCOVID-19will lead tochanges in how consumersmake purchases
the possibilitythat the economicimpact ofCOVID-19,and its associated highunemployment rate,will lead to less consumer spendingthus resulting in loss of revenues;
the possibility that the economic impact of COVID-19, will result in ourmerchants’ businesses failing to reopen once restrictions are further eased;
delay in orfailure to obtain regulatory approval ofour Secure TextPayment System or anyfuture products in additionalcountries;
our ability to operateour business while timelymaking payments toour loanagreements;
our need to raise additionalfinancing;
our ability to retain andrecruit appropriateemployees, in particular aproductive sales force;and
current and future laws andregulations.

All written and oral forward-lookingstatements attributable tous or any person acting onour behalf are expresslyqualified in their entiretyby the cautionary statements contained orreferred toin this section. Wecaution investors not to rely too heavily on the forward-looking statementswemake orthat are made onour behalf. Weundertake no obligationand specificallydeclineany obligation, to update orrevise any forward-lookingstatements, whether as aresultof new information,future events or otherwise. Pleasesee, however,anyfurther disclosureswemake on related subjects in anyannual, quarterly orcurrent reportsthatwemay filewiththeSecurities and Exchange Commission (SEC).

Weencourage you to readthe discussion and analysis ofourfinancial condition andour consolidated financial statementscontainedin thisAnnual Report on Form10-Q. There can beno assurance thatwewillinfact achieve the actualresults or developmentswe anticipate or,evenifwe do substantially realizethem,that theywill have the expected consequences to, oreffects on, us. Therefore,wecangive no assurancesthatwewill achieve theoutcomes stated in those forward-lookingstatements and estimates.

Unlessthecontextotherwise requires,throughoutthis Quarterly Report on Form 10-Q,the words “AppTech”“we,” “us,” the “registrant” orthe “Company”refer to AppTech Corp.


PART I – FINANCIAL INFORMATION

Item1. FinancialStatements

APPTECH CORP. AND SUBSIDIARIES

CONSOLIDATED FINANCIAL STATEMENTS

AS OF AND FORTHE THREE MONTHS ENDED MARCH 31, 2020 and 2019

INDEXTO CONSOLIDATED FINANCIAL STATEMENTS

Pages
Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019 (unaudited)5
Consolidated Statements of Operations for the three months ended March 31, 2020 and 2019 (unaudited)6
Consolidated Statements of Stockholders’ Deficit for the three months ended March 31, 2020 and 2019 (unaudited)7
Consolidated Statements of Cash Flows for the three months ended March 31, 2020 and 2019 (unaudited)8
Notes to Condensedthe Unaudited Consolidated Financial Statements (unaudited).9


3

APPTECH CORP. AND SUBSIDIARIES

NATURAL NUTRITION, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
  
Nine months ended September 30,
 
  
2008
 
2007
 
REVENUE
     
Sales revenue $12,264,672 $5,771,105 
Fee income  -  2,965 
Trading gains (losses)  (129,500) 3,897 
Dividends from marketable securities  36,257  9,015 
Interest income from notes and debenture receivable  167,462  206,309 
Total revenue  12,338,891  5,993,291 
        
OPERATING EXPENSES
       
Cost of sales revenue  9,790,380  4,767,414 
Selling, general and administrative expenses (2008 and 2007       
include $-0- and $199,835, respectively of expenses       
allocated from an affiliated entity)  4,396,710  3,417,787 
Total operating expenses  14,187,090  8,185,201 
OPERATING LOSS
  (1,848,199) (2,191,910)
        
OTHER (INCOME) EXPENSE
       
Net change in fair value of derivative  (6,389,641) 1,561,112 
Loss on sale of investment  11,480  - 
Interest and other income  (335,546) (33,776)
Interest expense  1,809,867  1,279,193 
Total other (income) expense  (4,903,840) 2,806,529 
        
Income (Loss) before provision for income taxes  3,055,641  (4,998,439)
        
INCOME TAX BENEFIT
  (68,800) (59,442)
NET INCOME (LOSS) APPLICABLE TO COMMON SHARES
 $3,124,441 $(4,938,997)
        
Net income (loss) per share - basic $0.06 $(0.31)
Net income (loss) per share - diluted $0.02 $(0.31)
        
Weighted shares outstanding - basic  49,855,367  16,060,568 
Weighted shares outstanding - diluted  145,965,917  16,060,568 
        
OTHER COMPREHENSIVE INCOME
       
        
NET INCOME (LOSS)
 $3,124,441 $(4,938,997)
        
Foreign currency translation income (expense) adjustment  (1,061,989) 1,194,593 
        
COMPREHENSIVE INCOME (LOSS)
 $2,062,452 $(3,744,404)
See accompanying Notes to Condensed Consolidated Financial Statements (unaudited).
4

NATURAL NUTRITION, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
  
Three months ended September 30,
 
 
 
2008
 
2007
 
REVENUE
     
Sales revenue $3,910,138 $4,201,764 
Trading gains (losses)  11,527  (8,114)
Dividends from marketable securities  7,332  546 
Interest income from notes and debenture receivable  49,249  52,826 
Total revenue  3,978,246  4,247,022 
        
OPERATING EXPENSES
       
Cost of sales revenue  3,173,853  3,467,897 
Selling, general and administrative expenses (2008 and 2007       
include $-0- and $50,114, respectively of expenses       
allocated from an affiliated entity)  2,048,882  1,152,694 
Total operating expenses  5,222,735  4,620,591 
OPERATING LOSS
  (1,244,489) (373,569)
        
OTHER (INCOME) EXPENSE
       
Net change in fair value of derivative  104,024  (1,201,440)
Interest and other income  (117,277) (16,538)
Interest expense  606,922  648,459 
Total other (income) expense  593,669  (569,519)
        
Income (Loss) before provision for income taxes  (1,838,158) 195,950 
        
INCOME TAX PROVISION (BENEFIT)
  4,024  (92,179)
NET INCOME (LOSS) APPLICABLE TO COMMON SHARES
 $(1,842,182)$288,129 
        
Net income (loss) per share - basic $(0.03)$0.01 
Net income (loss) per share - diluted $(0.01)$0.00 
        
Weighted shares outstanding - basic  66,104,072  19,259,139 
Weighted shares outstanding - diluted  154,924,622  2,209,918,984 
        
OTHER COMPREHENSIVE INCOME
       
        
NET INCOME (LOSS)
 $(1,842,182)$288,129 
        
Foreign currency translation adjustment  (662,948) 1,133,419 
        
COMPREHENSIVE INCOME (LOSS)
 $(2,505,130)$1,421,548 
See accompanying Notes to Condensed Consolidated Financial Statements (unaudited).
5

CONSOLIDATED BALANCE SHEETS
NATURAL NUTRITION, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
  
Nine Months Ended September 30,
 
 
 
2008
 
2007
 
CASH FLOWS FROM OPERATING ACTIVITIES
     
Net income (loss) $3,124,441 $(4,938,997)
Adjustment to reconcile net income to net cash       
provided by (used in) operating activities  (3,196,288) 5,900,519 
        
Net cash provided by (used in) operating activities  (71,847) 961,522 
CASH FLOWS FROM INVESTING ACTIVITIES
       
Cash acquired in acquisition  -  609,022 
Purchase of assets  (147,391) (95,223)
Sale of asset  -  100,000 
Net cash provided by (used in) investing activities  (147,391) 613,799 
CASH FLOWS FROM FINANCING ACTIVITIES
       
Proceeds from issuance of convertible note, net  -  1,070,910 
Payments on capital lease obligations  (47,606) (16,123)
Net cash provided by (used in) financing activities  (47,606) 1,054,787 
EFFECT OF EXCHANGE RATE CHANGE ON CASH
  21,317  164,893 
NET CHANGE IN CASH
  (245,527) 2,795,001 
CASH, BEGINNING OF PERIOD
  1,923,429  148,691 
CASH, END OF YEAR
 $1,677,902 $2,943,692 
        
SUPPLEMENTAL INFORMATION
       
Interest paid $750,000 $710 
Taxes paid $355,156 $- 
Purchase of INII:       
Fair value of assets acquired $- $18,985,445 
Liabilities assumed $- $4,720,596 
Discount on convertible note $- $2,185,159 
Embeded derivative and warrant liability $- $1,180,870 
Non-cash portion of convertible note payable $- $8,221,964 
Deferred finance costs $- $153,000 
Conversion of debentures, preferred stock and stock for services:       
Convertible debt    $12,000 
Preferred stock $(677)$8 
Common stock $32,200 $8,658 
Paid in capital $240,825 $87,443 
See accompanying Notes to Condensed Consolidated Financial Statements (unaudited).
6

Natural Nutrition, Inc.MARCH 31, 2020 and Subsidiaries
NotesDECEMBER 31, 2019
(UNAUDITED)

  March 31, December 31,
  2020 2019
     
ASSETS        
Current assets        
Cash $15,163  $24,159 
Accounts receivable  26,691   29,836 
Prepaid rent  4,910    
Deposit escrow     25,000 
Security deposit     5,948 
Total current assets  46,764   84,943 
         
Right of use asset  295,711    
Security deposit  7,537    
TOTAL ASSETS $350,012  $84,943 
         
LIABILITIES AND STOCKHOLDERS' DEFICIT        
Current liabilities        
Accounts payable $1,717,804  $1,707,878 
Accrued liabilities  2,399,213   2,334,480 
Right of use liability  39,002    
Stock repurchase liability  430,000   430,000 
Loans payable related parties  65,351   93,401 
Convertible notes payable  620,000   620,000 
Convertible notes payable related parties  372,000   372,000 
Notes payable  1,104,081   1,104,081 
Notes payable related parties  708,493   708,493 
Total current liabilities  7,455,944   7,370,333 
         
Long-term liabilities        
Accounts payable  140,000   160,000 
Right of use liability  264,342    
Total long-term liabilities  404,342   160,000 
TOTAL LIABILITIES  7,860,286   7,530,333 
         
Commitments and contingencies (Note 8)        
         
Stockholders' Deficit        
Series A preferred stock; $0.001 par value; 100,000 shares authorized; 14 shares issued and outstanding at March 31, 2020 and December 31, 2019      
Common stock, $0.001 par value; 1,000,000,000 shares authorized; 86,503,325 and 84,153,825 and outstanding at March 31, 2020 and December 31, 2019, respectively  86,504   84,154 
Additional paid-in capital  34,627,685   33,230,869 
Accumulated deficit  (42,224,463)  (40,760,413)
Total stockholders' deficit  (7,510,274)  (7,445,390)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $350,012  $84,943 

See accompanying notes to Condensed Consolidated Financial Statementsthe consolidated financial statements.


APPTECH CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED MARCH 31, 2020 and 2019
(UNAUDITED)

  March 31, March 31,
  2020 2019
     
Revenues $58,157  $56,800 
         
Cost of revenues  23,225   22,537 
         
Gross profit  34,932   34,263 
         
Operating expenses:        
General and administrative, including stock based compensation of $1,209,185 and $7,208, respectively  1,415,899   189,645 
Research and development  12,000   6,820 
         
Total operating expenses  1,427,899   196,465 
         
Loss from operations  (1,392,967)  (162,202)
         
Other income (expenses)        
Interest expense  (71,083)  (76,039)
         
Total other expenses  (71,083)  (76,039)
         
Loss before provision for income taxes  (1,464,050)  (238,241)
         
Provision for income taxes      
         
Net loss $(1,464,050) $(238,241)
         
Basic and diluted net loss per common share $(0.02) $(0.00)
         
Weighted-average number of shares used basic and diluted per share amounts  84,289,100   86,922,132 

See accompanying notes to the consolidated financial statements.

(Unaudited)

APPTECH CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
FOR THE THREE MONTHS ENDED MARCH 31, 2020 and 2019
(UNAUDITED)

 Series A Preferred Common Stock      
 Shares Amount Shares Amount Additional
Paid-
in Capital
 Accumulated
Deficit
 Stockholders'
Deficit 
Balance December 31, 2018  14  $   86,797,132  $86,797  $32,284,735  $(39,417,203) $(7,045,671)
Net loss                 (238,241)  (238,241)
Imputed interest              3,450      3,450 
Common stock issued for subscriptions        275,000   275   68,475      68,750 
Common stock issued for services        12,000   12   7,196      7,208 
Common stock cancelled        (3,450,000)  (3,450)  3,450       
Proceeds from sale of repurchase option              123,750      123,750 
Balance March 31, 2019  14  $   83,634,132  $83,634  $32,491,056  $(39,655,444) $(7,080,754)
                             
Balance December 31, 2019  14  $   84,153,825  $84,154  $33,230,869  $(40,760,413) $(7,445,390)
Net loss                 (1,464,050)  (1,464,050)
Imputed interest              3,450      3,450 
Common stock issued for services        2,349,500   2,350   1,206,835      1,209,185 
Proceeds from sale of repurchase option              186,531      186,531 
Balance March 31, 2020  14  $   86,503,325  $86,504  $34,627,685  $(42,224,463) $(7,510,274)

See accompanying notes to the consolidated financial statements.


APPTECH CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED MARCH 31, 2020 and 2019
(UNAUDITED)

  March 31, March 31,
  2020 2019
     
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $(1,464,050) $(238,241)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock issued for services  1,209,185   7,208 
Imputed interest on notes payable  3,450   3,450 
Depreciation and amortization     16 
Changes in operating assets and liabilities:        
Accounts receivable  3,145   (98)
Prepaid rent  (4,910)    
Accounts payable  (10,074)  106,039 
Accrued liabilities  64,733   (69,035)
Right of use asset and liability  7,633    
Net cash used in operating activities  (190,888)  (190,661)
         
CASH FLOWS FROM INVESTING ACTIVITIES        
Deposit escrow  25,000    
Security deposit  (1,589)   
Net cash provided by investing activities  23,411    
         
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds (payments) on loans payable - related parties  (28,050)  69,500 
Payments on notes payable     (36,000)
Proceeds from sale of repurchase option  186,531   123,750 
Proceeds from sale of common stock     68,750 
Net cash provided by financing activities  158,481   226,000 
         
Changes in cash and cash equivalents  (8,996)  35,339 
Cash and cash equivalents, beginning of period  24,159   1,384 
Cash and cash equivalents, end of period $15,163  $36,723 
         
Supplemental disclosures of cash flow information:        
Cash paid for interest $  $ 
Cash paid for income taxes $  $ 

See accompanying notes to the consolidated financial statements.


APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 -ORGANIZATION AND DESCRIPTION OF BUSINESS

AppTech Corp.(“AppTech” orthe “Company”) is a Wyoming Corporation incorporatedon July 2, 1998.

AppTech Corp. is a FinTechcompany providing electronicpayment processingtechnologies and merchant services. Thisincludes credit cardprocessing, Automated ClearingHouse (“ACH”)processing, gift andloyalty cardsande-commerce. The Company expanded its core services to includeglobal ShortMessaging Service (“SMS”) patentedtext messaging andsecure mobile payments based on Multi-factor authenticationtechnologies. The patentedtwo-way text chat platform enablessecure SMS servicesincluding mobilepayments, notifications, authentication,marketing, information queriesand reporting. Other services includedigital marketing, lead generation,mobile appdevelopment, and intellectual property rights development.

NOTE 2 - BASISSUMMARY OF PRESENTATIONSIGNIFICANT


Our Condensed Consolidated Balance Sheet as ACCOUNTING POLICIES

Basis of September 30, 2008, the Condensed Consolidated Statements of Operations for the nine and three months ended September 30, 2008 and 2007, and the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2008 and 2007 Presentation

TheCompany’s consolidatedfinancial statementshave not been audited. These statements have been prepared on a basis that is substantially consistent with the accounting principles applied in our Annual Report on Form 10-KSB for the fiscal year ended December 31, 2007. In our opinion, these financial statements include all normal and recurring adjustments necessary for a fair presentation of Natural Nutrition, Inc. (the “Company”) and Subsidiaries. The results for the nine months are not necessarily indicative of the results expected for the year.


As used herein, the “Company”, “management”, “we” and “our” refers to Natural Nutrition, Inc., or Natural Nutrition, Inc. together with its subsidiaries. The Company's fiscal year ends on December 31st.
Certain information and footnote disclosures normally included in financial statements prepared in accordancewith accounting principles generally accepted inthe United States ofAmerica (“U.S. GAAP”).Also see Note 3.

Principles of Consolidation

TheCompany’s accounts includefinancials ofthe Company and itswholly owned subsidiaries,Transcendent One,Inc. and TransTechOne, LLC. All significant inter-company transactionshave been omittedeliminatedinconsolidation. Theoperations ofTranscendent One, Inc. and TransTech One,LLC areinsignificant and the Company dissolvedthe subsidiarieson October8,2019.

Use of Estimates

The preparation ofthe consolidatedfinancial statementsin conformitywith generally acceptedaccounting principlesrequires management tomake estimatesand assumptions that affectthe reportedamounts of assetsand liabilitiesand disclosure ofcontingentassetsand liabilities at the dateof the consolidatedfinancial statementsand the reportedamounts ofrevenuesand expensesduring the reporting period.Significant estimates include the estimated liabilities related tovarious vendors in accordancewhich communicationshave ceased,contingent liabilities, and realization of tax deferred tax assets.Actual results coulddifferfromthose estimates.

Concentration ofCredit Risk

Cashandcash equivalents aremaintained atfinancialinstitutions and, attimes, balances mayexceedfederallyinsuredlimits of $250,000 perinstitution that pays Federal DepositInsuranceCorporation(“FDIC”) insurancepremiums.The Companyhas never experienced any losses related tothese balances.

Theaccounts receivablefrom merchant services are paidby thefinancial institutions on amonthly basis. The Companycurrently uses three financial institutions toservice their merchantsfor which represented 100% ofaccounts receivable as of March 31, 2020and 2019. Theloss ofone of thesefinancial institutions would not have asignificant impact on the Company’s operations asthere areadditional financial institutions available tothe Company. Forthe three months ended March 31, 2020and2019,the one merchant (customer)represented approximately 43%and 40% ofthe totalrevenues, respectively. Theloss ofthis customerwould have significantimpactonthe Company’s operations.

Cash andCash Equivalents

The Company classifies itshighly liquidinvestments with maturities of threemonths or less at the published rulesdate ofpurchaseascash equivalents. Management determines the appropriateclassification of its investments at thetimeofpurchase and regulationsreevaluatesthe designations of eachinvestment asofthe balance sheet datefor each reporting period. The Company classifies itsinvestmentsaseither short-term or long-term based on eachinstrument’s underlying contractualmaturitydate. Investmentswith maturities of less than 12months areclassified as short-term andthose with maturities greater than 12months areclassifiedas long-term. The cost ofinvestments sold is based uponthespecific identificationmethod.


APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable isrecorded net of anallowance for doubtful accounts,if needed. The Companyconsiders any changes tothe U.S. Securitiesfinancial condition of itsfinancial institutions used and Exchange Commission (the “SEC”)anyother external market factors that could impact the collectability of its receivables inthe determination of itsallowance for interimdoubtful accounts. The Company does notexpect tohave write-offs oradjustments to accounts receivablewhich could have amaterial adverse effect on its consolidatedfinancial position, results of operations orcash flows asthe portionwhich is deemeduncollectible is already takeninto account when therevenueisrecognized.

Revenue Recognition

TheFinancial Accounting Standards Board(“FASB”) issuedAccounting Standards Update(“ASU”) No. 2014-09,codified asAccounting Standards Codification (“ASC) 606 Revenue from Contractswith Customers,which provides asingle comprehensive model for entities touse inaccounting for revenue arising from contractswith customers. The Company adoptedASC 606effective January 1, 2019using modified retrospective basisand the cumulativeeffect was immaterial tothe consolidated financial statements.

The unaudited Condensed Consolidated Financial StatementsCompany providesmerchant processing solutionsforcredit cardsand electronic payments. In all cases,the Company acts as an agent between themerchant which generates the credit cardand electronic payments, and the notes thereto bank which processes suchpayments. TheCompany’s revenue isgenerated on services priced as apercentage of transactionvalue or aspecified fee transaction, depending onthe card ortransaction type.Revenue is recorded as services are performedwhich is typically whenthe bank processes themerchant’s credit cardand electronic payments.

The Company provides various Cloud services to business clients. Revenuesgenerated from the servicesas agreed upon in this report shouldaCloud ServiceAgreement. Therevenue is recorded asthe services are performedand billed inadvanceon amonthly basis.Revenues from these servicesrepresent less than 5% ofthe Company’s total revenues.

Consideration paid tocustomers, such as amountsearned under our customer equity incentiveprogram, arerecorded as a reduction torevenues.

Fair Value of Financial Instruments

ASC 820, FairValue Measurements andDisclosures definesfair value as the pricethat would be readreceived tosellan asset or paid totransfer a liability in conjunction an orderly transaction betweenmarket participants at themeasurement date. ASC 820 alsoestablishes afair value hierarchy thatrequires an entity tomaximize the use of observableinputs and minimize theuse ofunobservable inputs when measuring fair value.

The standard describesthree levels of inputs that may be used tomeasure fairvalue:

Thefair value hierarchy prioritizesthe inputs used in valuationtechniques into three levels asfollows:

Level 1Observableinputs – unadjusted quoted prices inactive marketsfor identical assetsand liabilities;
Level 2Observable inputs –other thanthe quoted pricesincluded inLevel 1that are observablefor the asset or liabilitythrough corroborationwith market data;and
Level 3Unobservableinputs – includes amounts derived from valuationmodels where one ormore significant inputs areunobservable.

TheCompany’s financial instruments consist of cashand cash equivalents, accounts receivable, vendordeposits, accounts payable, accrued expenses, etc. Thecarrying value ofthese assets and liabilitiesisrepresentative oftheirfair market value,due tothe audited Consolidated Financial Statementsshort maturity of these instruments.

Research and notes thereto included in our Annual Report on Form 10-KSB Development

In accordancewith ASC 730, Research andDevelopment (“R&D”) costs areexpensed when incurred.R&Dcosts include costs ofacquiring patents andother unproven technologies, contractorfees and other costs associatedwiththe developmentof the SMSshortcodetextingplatform,contract and other outside services. TotalR&D costsfor the fiscal year three monthsended December March31, 2007 (the “10-KSB”).

2020and2019were $12,000and $6,820,respectively.


Natural Nutrition, Inc. (the “Company”) was incorporated

APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Property and Equipment

Propertyand equipmentis recorded at cost.Expenditures for major additionsand betterments are capitalized. Maintenanceand repairs arecharged tooperations as incurred. Depreciation of propertyand equipmentiscomputedby the straight-linemethod (after taking intoaccount theirrespective estimated residual values)over the assets estimateduseful life offive (5) years. Uponsale orretirementof equipment,the related costand accumulated depreciation areremoved from the accounts and any gain orloss is reflected in Floridathe consolidatedstatements of operations.

Impairment of Long-LivedAssets

Long-lived assets are reviewedfor impairment when thereis evidencethat events or changes in circumstances indicate thatthe carrying amount of anasset orasset group may not berecoverable. Recoverability of assets to beheld and used ismeasuredbycomparing thecarrying amount of anasset orasset group to estimatedundiscounted future cash flows expected to begenerated by theasset orasset group. If the carrying amount of anasset orasset group exceeds itsestimated future cashflows,animpairment charge is recognizedfor the amountby whichthecarryingamount of the asset orasset group exceeds the estimatedfair value ofthe asset orasset group. Long-lived assets tobe disposed of bysale arereported atthe lower of theircarrying amounts or theirestimated fair values less costs to selland arenot depreciated.As of March 31, 2020and December 31,2019,there were no asset impairments.

Lease Commitment

The Company determinesif anarrangement is a lease atinception. This determination generally depends on July 2, 1998. On August 25, 2005,whetherthe arrangement conveys tothe Company theright to control theuse of an explicitly or implicitlyidentified fixed assetfor a period oftimeinexchange for consideration. Control ofanunderlying asset isconveyed tothe Companyif the Company completedobtains the closingrights to directthe use of that certain Share Exchange Agreement, byandto obtainsubstantially all of theeconomic benefits from usingthe underlying asset. The Companyhas lease agreements which include lease and betweennon-leasecomponents, which the Company CSI Business Finance, Inc.,has elected to accountfor as a Texas corporationsingle leasecomponent for all classes of underlying assets.Lease expense for variable lease components are recognizedwhen the obligation is probable.

Operating leaseright ofuse (“ROU”)assets and now wholly-owned subsidiary lease liabilities arerecognized atcommencement date based onthe present valueof lease paymentsover the leaseterm. Operating leasepayments arerecognized as lease expense on a straight-line basisover the leaseterm. The Company primarily leases buildings (real estate) which are classifiedas operating leases. ASC 842requires alessee to discount itsunpaid lease payments using the interest rate implicitinthe lease or, ifthat rate cannot be readilydetermined, itsincremental borrowing rate. As an implicit interest rate isnot readily determinable in the Company’s leases,the incremental borrowing rate isused based on the information available at commencement date in determining thepresent value of leasepayments.

The lease termfor all ofthe Company’s leasesincludes the non-cancellable period ofthe leaseplus any additional periods covered byeither a Company option toextend (ornot toterminate) the lease thatthe Company is reasonably certain to exercise, or an option toextend (ornot toterminate) the lease controlled bythe lessor.Options for leaserenewals have been excluded from the lease term(and leaseliability) for the majority of theCompany’s leases asthe reasonably certain threshold isnot met.

Lease payments included inthe measurement ofthe lease liability arecomprised of fixedpayments, variable paymentsthat depend onindex or rate,and amounts probable to be payableunder the exercise of the Company herein referredoption topurchase theunderlying assetif reasonablycertain.

Variable leasepayments not dependent on a rate orindex associatedwiththeCompany’s leases arerecognizedwhen theevent, activity, orcircumstanceinthe leaseagreementonwhich thosepayments areassessedas ("CSI-BF")probable.Variable leasepaymentsarepresented as operating expenses inthe Company’sstatement of operationsin thesame line asexpensearising fromfixed leasepayments.As of March 31, 2020,management determinedthat there were no variable leasecosts.


APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

IncomeTaxes

The Company recognizes deferred taxassets andliabilities forthe expectedfuturetax consequences of eventsthat havebeenincluded in the consolidatedfinancialstatements or tax returns. Under this method, deferred tax assets and liabilities are based onthe differences betweenthe financial statement and tax bases of assetsandliabilities using enacted tax rates in effect forthe fiscal yearinwhichthe differences are expected toreverse.Deferred tax assets are reduced by avaluation allowancetotheextentmanagement concludes it ismorelikely thannot that the assetswill not be realized. Deferred tax assetsandliabilities aremeasured using enacted tax rates expected to apply to taxableincomein thefiscal yearsinwhichthosetemporary differences are expected to be recoveredorsettled. Theeffecton deferred tax assets and liabilitiesofachangein tax rates is recognized inthe consolidated statement of operations intheperiodthatincludes theenactment date.

TheCompany’s income tax returns are based on calculationsand assumptions that are subject toexaminationby the InternalRevenue Service and other taxauthorities. In addition,the calculation ofthe Company’s tax liabilitiesinvolves dealingwithuncertainties in the application of complex tax regulations.The Company recognizes liabilitiesfor uncertain tax positions based on atwo-step process. Thefirst step is toevaluate the tax positionfor recognitionby determiningifthe weight of availableevidence indicatesthat it ismore likely thannot that the positionwill besustained on audit,including resolutionof related appeals orlitigation processes, ifany. Thesecond step is tomeasure the tax benefit asthe largest amountthat ismore than 50% likely of being realized uponsettlement. Whilethe Company believes ithas appropriate supportfor the positionstakenon its taxreturns, the Company regularly assessesthe potential outcomes ofexaminationsby tax authorities in determiningthe adequacyofitsprovision for income taxes. The Company continually assesses the likelihoodand amountof potential adjustmentsand adjusts theincome tax provision,income taxes payableand deferredtaxes in the period in whichthefacts thatgive rise to arevision become known. As of March 31, 2020and 2019,the Company doesnot believe anyprovisionsarerequired inconnection with uncertain tax positions as there arenone.

PerShare Information

Basicnet income (loss) percommon share iscomputed by dividingnet income (loss) by theweighted average number ofshares of common stockoutstanding during the period.Diluted netincome (loss) per commonshare is computed by dividingnet income (loss) bythe weighted average number of shares of commonstock and potentiallyoutstanding shares of commonstock during the period.

As of March 31, 2020and 2019,the Companyhad potentialdilutive securities related tooptions, warrants, Series A preferredstock and convertiblenotes payable. Thesedilutive securitieswere not includedwithinthecalculationofdilutive net loss per common share asthe effectswould have been anti-dilutive.

Convertible Debt

Convertible debt is accountedfor underthe guidelines establishedbyASC470-20 Conversionand Other Options. ASC 470-20governs the calculationof an embeddedbeneficial conversion,which is treated asan additional discount to the instrumentswhere derivativeaccountingdoesnot apply. Theamount of thevalueof additional stock andother considerationin addition tothe beneficial conversionfeature may reduce thecarrying valueofthe instrument to zero,but no further. The discounts are accretedover the term of the debtusing the straight linemethod due tothe short terms of thenotes.

The Company accountsfor modifications of its embeddedbeneficial conversions, in accordancewith ASC470-50 Modificationsand Extinguishments. ASC470-50requires the modification of a convertible debtinstrument that changesthe fair value of an embeddedconversion feature and the shareholdersubsequent recognition of CSI-BF (the "CSI-BF Shareholder"). In Septemberinterest expense orthe associated debtinstrument whenthe modification does notresultin a debtextinguishment.

StockBased Compensation

The Company recognizes as compensation expense all share-basedpayment awardsmadetoemployees, directors,and consultants includinggrantsof stock options andwarrants, based onestimated fair values. Fairvalue is generallydeterminedbased onthe closing price of 2006, CSI Business Finance, Inc. changed its namethe Company’s commonstockonthe date ofgrant and is recognizedover the service period. The Company hasseveralconsultingagreementsthathave sharebasedpaymentawards based onperformance.Theseagreements typicallyrequire theCompany to Natural Nutrition, Inc. and simultaneously redomiciled from Florida to Nevada.

On August 25, 2005, the Company effectively exchanged with the CSI-BF Shareholder the issued and outstandingissue common stock of CSI in exchange for 100,000 shares of Series A Convertible Preferred Stock, partothe consultants on amonthly basis. The Companyrecordsthe fair market value $0.01 per share, of the Company, and CSI-BF became a wholly-owned subsidiary of the Company. Each share of the Company's Series A Preferred Stock is convertible into 780 shares of common stock of the Company, beginning one year after the effective date of the merger. The Preferred shares were subsequently distributed to the shareholders of Corporate Strategies, Inc., the former shareholder of CSI-BF. In addition, at the exchange date, 5,408,576 shares of common stock of the Company were issued to pay off notes and debentures. If the preferred shareholders were to convert to common stock as of the date of the merger, they would hold 97,500,000 shares, or ninety-two and one half percent (92.5%) of the issued and outstanding shares of common stock of the Company. This conversion would result in the Series A Convertible Preferred shareholders effectively controlling the Company.

The Series A and Series B Convertible Preferred shareholders and the holders of the common stockissuableat eachmonth end when the performance is complete based upontheclosingmarket price ofthe Company’s commonstock. The Company hasentered into board of directors agreements thathave share basedpaymentawards based onservice. Theseagreements require the Company toissue commonstocktothe directors,earned on amonthly basis,over theoneyear term of theagreement. The Company vote togetherrecordsthe fair market valueofthe commonstock issuable atthe end ofthe month when the director isappointed totheboard basedupon the closingmarketprice oftheCompany’s common stock


APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

New Accounting Pronouncements

TheFASB issues ASUs toamend the authoritative literature inASC. Therehave been anumber of ASUs to datethat amend the original text ofASC. The Company believesthose issuedto dateeither (i) provide supplementalguidance, (ii) are technicalcorrections, (iii) arenot applicable tothe Company or(iv) arenot expected tohave a significant impact onthe Company.

NOTE 3 –GOING CONCERN

Asreflected in the accompanying consolidatedfinancial statements,during thethree months ended March 31, 2020and2019,the Company incurred anet lossof $1,464,050and $238,241and used cash of $190,888and $190,661 in operating activities. In addition,the Companyhad aworking capitaldeficit of $7,409,180and anaccumulated deficit of $42,224,463 atMarch 31, 2020. Thesefactors raise substantial doubt regarding the Company’s ability tocontinueas agoing concern. Wehave evaluatedthe conditions or eventsthat raisesubstantial doubt aboutthe Company’s ability as agoing concern within one year of issuance ofthe consolidatedfinancial statements.

While the Company is continuing operationsand generatingrevenues, the Company’s cash position isnot significant enough to supportthe Company’s daily operations.Tofund operations andreduce the working capitaldeficit,weintend to raise additionalfunds through public orprivate debt and/or equityofferings. During 2020,the Company raised$205,781from asale of arepurchase option tofund operations.Management believesthat the actions presently being taken tofurther implement itsbusinessplan andgenerate revenues provide the opportunityfor the Company to continue as agoing concern, however, such arenot guaranteed.While the Company believesin the viabilityofits strategy togenerate revenues and in its ability to raise additionalfunds, therecan beno assurances to thateffect, nor canthere beassurance that such fundswill be at acceptableterms. As ofthe date oftheseconsolidatedfinancial statements, the Companyhas notfinalized acommitment for additionalcapital. The ability ofthe Company tocontinue as agoing concern is dependent uponour ability tofurther implement itsbusiness planand generate revenues and cashflows. Theconsolidated financial statements donot include any adjustments thatmight be necessaryifthe Companyis unable to continue as separate classes,agoing concern.

Risks and uncertainties

On January 30, 2020,the World Health Organization declaredthe Preferred Stock shallcoronavirus outbreak a“Public Health Emergency ofInternational Concern”and on March 10, 2020,declaredit to be counted on an "as converted" basis, thereby giving apandemic. Actions takenaroundthe Preferred shareholders controlworldtohelp mitigate the spread of the Company.coronavirusinclude restrictions ontravel, and quarantinesin certainareas,and forced closures for certaintypes of public placesand businesses. The transaction was accounted forcoronavirus and actions taken tomitigate ithave had and are expected tocontinuetohave anadverse impact on theeconomies and financial markets ofmany countries, including thegeographical areain which the Company operates.Sincewe deriveour revenues from processing of purchases fromour merchant servicesclients, a downturn in economic activity,suchas associatedwith the currentcoronavirus pandemic,could reducethevolume of purchaseswe process,and thus our revenues. In addition, such a downturn could causeour merchant customers to cease operationspermanently decreasingour payment processing unless new customers arefound. We may alsoface additional difficulty in raising capitalduringan economicdownturn. Theeffects ofthe potential impact cannot beestimated atthis time.

Additionally,itis reasonably possiblethatthe estimates made in thefinancial statementshave been,orwill be materially and adversely impacted in thenearterm as a reverse acquisition since controlresult of theseconditions.


APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 4 –PATENTS

Patents

OnJune22, 2017,AppTech executedanAmendmentto AssetPurchase Agreement with GlobalTelMedia, Inc. Inconnection with the asset purchaseagreement,5,000,000shares of common stockwere issued to GlobalTelMedia, Inc. The Companyvaluedthe common stock issuance at $1,000,000 based onthe closingmarketprice ofthe Company’s common stock onthedate in which the performancewas complete. Thisamendmentrevived theoriginal asset purchase agreement datedDecember4, 2013 topurchase the assets of GlobalTel Media,Inc.(AppTechand GlobalTelagree that the asset purchase agreement dated September 30, 2015 isnull andvoid), which include,but isnot limited to, allintellectual property,United States Patent Trademark Office (“USPTO”)issued patents, enterprise-grade, patent protectedsoftware and intellectual propertyfor advanced messagingincorporating securepayments, databases, documentation,copyrights, trademarks,registrations, and allcurrent developmentwork in process of USPTO applicationapproval; more specificallybut not limited to USPTO 8,073,895 & 8,572,166“System and MethodforDelivering WebContent to a Mobile Device”,USPTO8,315,184“Computer to Mobile Two-WayChatSystem and Method”,andUSPTO8,369,828“Mobile-to-MobilePayment System and Method”. GlobalTel’s technologyfocuses on SMS text-based applications, socialmedia and mobile payment. The USPTOassigned thepatentsto AppTech on July 25, 2017. AppTech, as part ofthe various agreements,agreedto pay $1,600,000which included an assumption of certain liabilities,includingcostsincurred tocontinue developmentof the patents,aswellasguaranteedpayment of 25% ofthe net proceeds onrevenue created by the patentsup to $26,600,000. As of March 31, 2020and December 31,2019,amounts included inaccounts payable related tothe assumption of liabilities in connectionwith the patentswere$380,000and $415,000, respectively. The Company has expensed the cost of the Company passedpatents as research and development costsasthe future estimated cash flow expected cannot be reasonably estimated.

NOTE 5 – ACCRUEDLIABILITIES

Accrued liabilitiesas of March 31, 2020and December 31, 2019consist of thefollowing:

  March 31, 2020 December 31, 2019
     
Accrued interest – related parties $951,559  $943,356 
Accrued interest – third parties  1,275,129   1,215,699 
Accrued residuals  36,251   39,064 
Accrued merchant equity  91,023   91,023 
Other  45,251   45,338 
Total accrued liabilities $2,399,213  $2,334,480 

Accrued Interest

Notes payable and convertiblenotes payable incur interest at rates between 10%and 15%, perannum. Theaccrued interest inmost cases is currently in technicaldefault due to the shareholdersnotes being pasttheir maturity date.

Accrued Residuals

The Company payscommissions to independent agents whichrefer merchant accounts. Theamountspayable tothese independent agents is based upon apercentage ofthe amounts processed on amonthly basisby thesemerchant accounts.

Accrued Merchant Equity Liability

TheCompany provided allmerchants the opportunity toearn shares ofthe Company’scommonstock throughtheir Merchant Equity Program (the“Program”). Underthe acquired company (CSI-BF).


On January 29, 2008, our BoardProgram, themerchant earned 1% of Directors approvedtheir total Visa/MasterCardvolume processedduring the first year of theircontract. Forexample,if a 5 for 4 forwardmerchant processes $1.0millionin credit cardcharges, the merchant will receive 10,000shares ofthe Company’s common stock split. All references to our common stock in this document are stated in shares after the forward stock split. Our Board of Directors had previously approved a 1 for 25 reverse common stock split on May 23, 2006.


7

NOTE 2. INCOME (LOSS) PER COMMON SHARE AND STOCK BASED COMPENSATIONwhich
Net Income (Loss) Per Common Share
In accordance with SFAS No. 128, "Earnings per Share", basic earnings per share are computed based on the weighted average shares of commonstock outstanding during are notknown as they arewithin the one-year period,the Companyestimates on a quarterly basis as tothe periods.  Diluted earnings per shareestimated amount of shares based uponthe expectedamount to be processedbythemerchant on an annualbasis. Atthe end ofthe first year, when the number of shares issuable isknown, the Companymakesanadjustment tothe valueofthe shares,if needed.

The Company accountsforthevalue ofthe shares under the program as asales incentive and thus theamountsin connectionwith the Program are computed based on recorded as a reduction to revenues. As of March 31,2020,the Company has an obligation toissue approximately 776,000sharesofthe weighted average Company’s common stockissuableunderthe Program. During the year endedDecember31, 2019,the Company issued 37,193sharesof common stock plus relieving $14,877 in liability underthe assumedprogram.


APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 6 – NOTES PAYABLE AND CONVERTIBLE NOTES PAYABLE

TheCompanyfunds operationsthrough cashflows generated from operationsand the issuance ofloans and notes payable. Thefollowingis a summary of loans and notes payable outstanding asof March 31, 2020and2019.Related partiesnotedbelow areeither membersofmanagement,board of directors,significant shareholders or individuals inwhich have significantinfluence over the Company.

Loans Payable – RelatedParties

During thethree months ended March 31, 2020and 2019,theCompany obtained (paid) $(28,050)and$69,500loans payable from related parties,net.As of March 31, 2020and December31,2019,thebalance oftheloans payablewas$65,351and $93,401, respectively. The loans payable are due on demand, unsecured and non-interest bearing as there are no formal agreements executed.

Subordinated Notes Payable

In 2016,the Companyissued $350,000 insubordinated notes payable to third parties. The subordinatednotes payablewere due in 30 to180 days andincurred interest at 10% perannum. As of March 31, 2020and December 31, 2019,accrued interest related tothe subordinated notes was $127,295and $118,545,respectively. The Company is currently in default ofthe subordinated note agreements.

Convertible Notes Payable

In 2017,the Company received $222,000 inconvertible notes payable from related parties. Theconvertible notes payable areunsecured, were duein 180days, incur interest at 10% per annum and areconvertible at $0.10 pershare.As of March 31, 2020and December 31, 2019,accrued interest related tothe convertible noteswas $59,538and $53,988,respectively. Onthe date ofthe agreement, Management calculated the beneficial conversionfeaturein connectionwith the convertiblenotes payableand recorded adiscount of $222,000. The Companyamortized the discountover the term of the convertiblenotes payable of 180days. The Company is currently in default on the convertiblenotes payable.

In 2015,the Companyissued $50,000 inconvertible notes payable.Theconvertible notespayable areunsecured, were dueinnine months, incur interestat 10% perannum and areconvertible at $1.00 pershare.Asof March 31, 2020and December31, 2019,the accrued interest related tothe convertible noteswas $22,084and $20,833,respectively. The Company is currentlyindefaultonthe convertiblenote payable.

In 2014,the Company issued $400,000 inconvertible notes payable. Theconvertible notes payable areunsecured, due in periodsranging up toone year,incurring interest between 10% to 12% per annumand areconvertibleat pricesranging from $0.33 to $1.00 pershare.Inaddition, the Companyissued 400,000shares ofcommon stock inconnection with the convertiblenotes payable. TheCompany had the obligation to repurchasethe 400,000sharesofcommon stock at $1.00 pershare within one year ofthe note issuance date. As of March 31, 2020and December 31,2019, the Companyheld theobligation torepurchase the sharesfor all potentially dilutive securities.

$400,000. As of March 31, 2020and December 31, 2019,the accrued interest related tothe convertible noteswas$196,333and $186,083,respectively.The Companyis currently in default of thenote agreements.

In 2008and 2009,the Companyissued $320,000 inconvertible notes payable, ofwhich$150,000was from related parties. Theconvertible notes payable arecurrently due on demand, incurinterest at 15% perannum, andconvertible at $0.60 pershare.As of March 31, 2020and December 31, 2019,accrued interest related tothe convertible noteswas$528,013and $516,013 of which $249,000and $243,375, respectively, was due to related parties. The Company iscurrently indefault of thenotes payable agreements.

Notes Payable

In 2016,the Companyissued $143,000 innotes payable tothird parties. Thenotes payablewere duein ninety days orless. During 2019,the Company paid $36,000 innotes payable.The Company is currently in default of thenote agreements.

In 2007and2008,the Company enteredinto notespayablewith a related partyfor $46,000in proceeds. Thenotes payablewere due ondemand and incurred interest at 12% perannum. Thesewere combinedinto a singlenote agreementin2014. As of March 31, 2020and December 31, 2019,thebalance onthe note payable was $88,136and accrued interest related tothe note payable was $51,907and$49,243,respectively. The Companyiscurrentlyindefaultofthenote payable agreement.


Basic

APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

In 2007,theCompany enteredinto note payablewitha third partyfor $128,000 inproceeds.Underthe termsof the agreementthe holder received aflat interestamount of $37,496. The Companyiscurrentlyindefault ofthe note payable agreementand diluted earnings per share calculations are included below:

  Nine Months Ended Three Months Ended
 
 
 
September 30,
 
September 30,
 
 
 
2008
 
2007
 
2008
 
2007 
          
Income (loss) from continuing operations $3,124,441 $(4,938,997)$(1,842,182)$288,129 
Less effect of derivatives and convertible note and debenture  (7,715) 2,839,392  -  (552,992)
Net income (loss) $3,116,726 $(2,099,605)$(1,842,182)$(264,863)
              
Basic weighted average shares  49,855,367  16,060,568  66,104,072  19,259,139 
Effect of dilutive securities:             
Preferred stock  88,820,550  73,665,540  88,820,550  73,665,540 
Convertible note and debenture  7,290,000  2,116,994,305  -  2,116,994,305 
              
Diluted weighted average shares  145,965,917  2,206,720,413  154,924,622  2,209,918,984 
              
Income (loss) per share:             
Basic: $0.06 $(0.31)$(0.03)$0.01 
Diluted: $0.02 $(0.31)$(0.01)$(0.00)

A secured promissory note in the principalentire amount of $9,292,894 was outstanding$37,496 has been included within accrued interest. Since the note payable did not incur interest, the Company imputed interest at $3,200 and $3,200, respectively, which represented an interest rate of 10% per annum during the three months ended March 31, 2020 and 2019.

In 2008,the Company enteredinto anote payablewith a third partyfor $10,000 in total proceeds. Thenote payableis currently indefault and has aflat interestamount dueof $21,000.As of March 31, 2020and December 31, 2019,the Companywas indefaultofthe note agreementand the entireamountof $21,000has beenincluded within accrued interest.Since the notes payable donot incur interest, the Companyimputed interest at$250and $250,respectively, which represented an interest rate of 10% perannum during the threemonths ended March 31, 2020and 2019.

In 2008,the Company enteredinto notes payable with athird partyfor $26,000 in totalproceeds. Thenotes payable have aflatinterest amount due of $80,000. During 2015,the Companyreceived another $50,000from the thirdparty. During 2017,the Company entered into an agreement whereby theywould repay the principaland accrued interestin the amountof $145,000 byApril 4, 2018and issue the holders800,000 shares of commonstock. The Company recordedthe fair market value of the commonstock issued at $336,000 based onthe date ofissuance as interest expense.Other than theissuance of shares of commonstock, the Company didnot perform underthe agreement. The Company is currentlyin default ofthe note agreement.

In 2007,theCompanyentered into note payablewitha third partyfor $221,800 inproceeds.Thenote payable is currentlyindefault and incurs interest at 10% perannum.OnSeptember 30, 2008, but2013,the holder received an arbitrationsettlement fortheprincipaland accrued interest. As of March 31, 2020and December 31,2019,the Companywasin default ofthearbitration settlement. As of March 31, 2020and December 31,2019,accrued interest related to thenotepayablewas $439,931and $429,861, respectively.

In 2007,the Company enteredinto note payablewith a significant shareholderfor $58,600 in proceeds. Thenote payable iscurrently due ondemand and incursinterest at 10% perannum. As of March 31, 2020and December 31, 2019,accrued interest related tothe note payablewas $71,978and $70,513,respectively. The Company is currently indefault ofthe note agreement.

Two significant shareholdersfunded the Company’soperations throughnotes payable in primarily 2009and 2010and continue to support operations on alimited basis. Thenotes payable incur interest at 10% perannum andwere due onDecember 31, 2016. The Company is currently indefault of thenote agreements. As of March 31, 2020 andDecember 31, 2019,the aggregate balance ofthe notes payablewas $620,355and accrued interest was $591,114and $575,480,respectively.

NOTE 7 – RIGHT OF USE ASSET

Lease Agreement

In January 2020, the Companyentered into a lease agreementcommencing February 8, 2020for its conversion current facility which expiresin 2025. The term ofthe lease isfor five years. The Company also enteredinto a sixmonth option topurchase itscurrent facility under terms andconditions of the lease. At inception ofthe lease, the Company recorded arightofuse assetand liability. The Companyusedaneffective borrowing rate of 12%within the calculation.The following arethe expected leasepaymentsas of March 31, 2020,including the total amount ofimputedinterest related:

Years endedDecember 31, :

2020  $53,122 
2021   82,561 
2022   85,039 
2023   87,590 
2024   90,217 
2025   7,536 
   $406,065 
Less: Imputed interest   (102,721)
Total  $303,344 


APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 8 - COMMITMENTS AND CONTIGENCIES

Litigation

Shareholder Lawsuit

In March 2016, asignificant shareholder (“Plaintiff”) of the Companyfiled alawsuit againstthe Companyin the state ofCalifornia alleging breachof contract,fraud and negligent misrepresentation based on supposed oralpromises in 2013 togive Plaintiff’s companyshares were not includedinexchange for stocksin another company and a 2014consulting agreement. The Company strongly disputed all claims made in the computationlawsuit.OnApril20, 2017,theCompanyfiledan answerthat denied each and every purported allegationand cause of diluted per share net income action andfurther deniedthat they caused anydamage orloss. The Company reached anagreement resultingin a voluntary dismissal of the civilcase on July 5, 2017. ThePlaintiff was not able tofulfill the proper documentationwithin the allotted 180days and the 3,450,000shares of AppTech Corp stockwere properly cancelledin 2019.

Former ShareholdersLawsuits

InApril 2014, ashareholder of AppTechfiled a lawsuitagainst the Company inthe State of Washingtonclaiming breach ofcontract related tothe sale /transfer ofunregistered shares atthe time of AppTechacquisition. OnAugust 13,2014, the Companynotified the transfer agent and placed a’Stop Order’ onthe shares. The shareholderclaims thatthe 2.5million sharesreceived areunrestricted andshould bereflected assuch. OnAugust 19, 2014,the Companyfiled amotion to dismiss thelawsuit. Thelawsuit was dismissed on October 31,2014.

InNovember 2017,two shareholders of AppTech,onewhopreviouslyfiledthe 2014lawsuit in the State ofWashington, filed another lawsuit against the Companyinthe State of California, claimingthe same accusations asthe previously filedlawsuit whichwas dismissed. The lawsuit has been transferred tothe United StatesDistrict Courtfor the Southern District ofCalifornia. The Company filedthe defendants answer, affirmative defensesand counter claims.Management believes that thePlaintiff misrepresented and misled AppTechduring the merger. Thecourt has encouraged the parties tosettle. Even thoughthe Company believesthe lawsuit iswithout merit and will vigorously defend,theCompany hasmade several offers to settle. OnDecember 19, 2019,the Company enteredinto asettlement and release agreement. The Company has recordedthe liabilityas ofDecember 31, 2019for the total obligation of $240,000to be paidout over three years beginning February 15, 2020. The 2019impact is recorded inother expenses. A stipulation fordismissal of actionhas beenfiled withthecourts. As ofMay 14, 2020,we arecurrent on thepayment schedule.

Former Landlord Lawsuit

In September 2018,the landlordfor our former office space leasefiled alimited civillawsuit against the Companyin theState ofCalifornia. The Companyreached anagreement thatresultedin a stipulationfor judgment on October 28,2018. Thestipulated judgmentwas for $42,432including attorneyfees and court costsplus interest forwhich the Company recorded as a liabilityas ofDecember 31, 2018. The stipulatedjudgment was paid infull onAugust 16, 2019.

Patent AcquisitionLawsuit

In September 2018, acomplaint was filed in San Diego superiorcourt for a breach ofcontract arising from awrittenagreementfor the purchaseof a judgment towhich AppTechwas not aparty. The purchase ofthe judgment was part of the transaction toacquire the patents. AppTechsubstantially performedunder the agreement but the secondagreement toextend the final payment was executed underduress.On October 26, 2018, the Company filed ananswer that denied eachand every purported allegationand cause of actionand further deniedthat theycaused anydamage orloss. OnDecember 3,2019, the Company entered into aconditional settlement providing the terms of the conditionalsettlement have been completedby October 1, 2020. Theconditional settlement amount of $150,000 is paid inmonthly installments of $15,000. Thesettlement installments paidfor the three months ended SeptemberMarch 31, 2020 was $35,000.$5,000 was paid towardsthe March 31, 2020installment andthe April 30, 2008, because they were anti-dilutive. There were no similar potentially dilutive shares outstanding for2020installment was not paid. We arecurrently in default of the three monthsagreement and nine months ended September 30, 2007.

are in discussionswith the plaintiffs tocure the default prior to May 22,2020.

Significant Contract

In January 2019,theCompany enteredinto anagreement with a broker dealer to provide capital raisingactivities. Underthe termsofthe agreement the broker dealer is tomake aminimum of $90,000 in advisory fees. In addition,there are variousotherprovisions within the agreementwhich include a 10%placement fee, warrants topurchase common stock, a 4%transaction fee,etc.


APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Employeeversus ContractorClassification

The Company compensatesvarious individuals asconsultants. Annually, these consultants areissuedForm 1099sfor amounts paid tothem. In addition, theseconsultants donot have arrangements in which specify compensation payable tothem. The Companyrisks potential tax andlegal actions ifthese consultants aredeemed to beemployees bygovernmental agencies.

NOTE 39 – STOCKHOLDERS’DEFICIT

Series A Preferred Stock

The Companyis authorized to- PURCHASE OF THE SENIOR DEBT OF INTERACTIVE NUTRITION INTERNATIONAL, INC.issue

100,000Effective Mayshares of $0.001 parvalue Series A preferredstock (“Series A”). Therewere fourteen (14)shares of Series A preferredstock outstanding as of March 31, 2007, 2020and December 31,2019. The holders of Series A preferredstock areentitled toone vote pershare on an “asconverted” basis on allmatters submitted to avote of stockholdersand arenot entitled tocumulate theirvotes inthe election of directors. The holders of Series A preferred stock areentitled to any dividends that may be declared bytheBoard of Directorsout offunds legally available, therefore on apro rata basis according to their holdingsof sharesof Series A preferredstock, onan as convertedbasis. In the event of liquidation or dissolution ofthe Company, closed holders of Series A preferredstock areentitled toshare ratably in all assets remainingafter payment of liabilities andhave no liquidation preferences. Holders ofSeries A preferredstock have aright toconvert eachshare of Series Ainto 780shares commonstock.

Common Stock

The Company is authorizedtoissue 1,000,000,000shares of $0.001par value commonstock. Therewere 86,503,325and 84,153,825,respectively, shares ofcommon stockoutstanding as of March 31, 2020and December 31,2019. Theholders of commonstock areentitled toone vote pershare on a purchase agreement (the “allmatters submittedPurchase Agreement”) with Nesracorp. Inc., a company organized under the laws of Canada (the “Vendor”) pursuant to which the Company purchased from the Vendor,avote ofstockholders and the Vendor sold, assigned transferred and conveyed arenot entitled to the Company, all of Vendor’s right, title, benefit and interest in (a) all of the then outstanding principal and interest accrued thereon (the “cumulateIndebtedness”) owed to the Vendor by Interactive Nutrition International, Inc. (“INII”), a company organized under the laws of Canada and a wholly-owned subsidiary of the Company, under a promissory note their votes in the original principal amountelection of Fifteen Million Canadian Dollars (Cdn$15,000,000) issued (in part)directors. The holdersof common stock areentitled to any dividends thatmay be declared by INIIthe board of directorsout of funds legally available, therefore subject tothe priorrights of holders ofany outstanding shares of preferredstock and any contractual restrictions againstthe Vendor payment ofdividendson commonstock. Inthe event ofliquidation or dissolution ofthe Company, holders of common stock areentitled to share ratably in all assets remainingafterpayment of liabilities and theliquidation preferences ofanyoutstanding shares of preferredstock. Holders of commonstock have no preemptive orother subscription rightsand no right toconvert their common stockintoany othersecurities.

During the threemonths ended March 31, 2004 (the “2020andSubsidiary Note2019,”)the Company issued 2,349,500and12,000,respectively, shares of common stock to several consultants in connectionwith business development and (b)professional services. The Company valuedthe common stock issuances at $1,209,185and $7,208, respectively, based uponthe closingmarket price ofthe Company’s commonstock onthe date in whichthe performancewas complete. Theamounts were expensed togeneral and administrative expenses on the accompanyingconsolidated statementsof operations.

Common Stock Repurchase Option

On January 23, 2020,the Company enteredinto a general securitycommonstock repurchase option agreement topurchaseor assign 300,000sharesof even date with commonstock from athird party at $0.05 pershare. TheCompany assigned itsrights tothe Subsidiary Note, andrepurchase optionagreement to a share pledge agreement, of even date with the Subsidiary Note, both granted concurrently by INII and its shareholder,third partyinexchange for compensation. Thecommon stockrepurchaseoptionswere exercised on January 26, 2020for which the Company (as successorreceived $98,750 in interest to the now defunct Bio One Corporation) in connection with the Indebtedness (together, both instruments are hereinafter referred toproceeds whichwas recorded as the “additionalSecuritypaid-in capital.

On February 26, 2020,”) for a purchase price equal to (i) Seven Million Six Hundred Fifty Thousand Canadian Dollars (Cdn$7,650,000) and (ii) the execution by the Company enteredinto a commonstock repurchase optionagreement topurchase orassign266,115shares of that certain Mutual Release.commonstock from athird party at $0.05 pershare. TheCompany and assigned itsrights tothe Vendor entered into an Assignment and Conveyance (“repurchase optionAssignmentagreement”), of even date with the Purchase Agreement, to a third party in order to properly effectuate the assignment by the Vendor toexchangefor compensation. The commonstock repurchase optionwas exercised on February 27, 2020for which the Company of all of the right, title, benefit and interestreceived $25,281 in and to the Purchased Assets (as defined therein),proceeds which such Purchased Assets include, without limitation, the Indebtedness, the Security and all loan, security and other documentation relating to the Indebtedness and the Security purchased under the Purchase Agreement.  The Company and the Vendor executed the Purchase Agreement, the Mutual Release and the Assignment on May 25, 2007; however they closed the transactions upon the execution of the SPA (as defined and discussed herein below) on May 31, 2007.was


8

recorded asadditional paid-in capital.

On May 31, 2007, March 18, 2020,theCompany entered into a securities purchasecommonstock repurchase option agreement (the “topurchaseor assign 250,000SPAshares of common”) with YA Global Investments, L.P. (f/k/stockfrom a Cornell Capital Partners, LP and herein referredthird party at $0.05 pershare.TheCompany assigned itsrights tothe repurchase optionagreement to as the “athird party inInvestorexchange for compensation. The common”) pursuant tostock repurchase option was exercised on March 19, 2020for which the Company soldreceived $62,500 in proceeds whichwasrecorded asadditional paid-in capital.


APPTECH CORP. AND SUBSIDIARIES

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 10 – SUBSEQUENTEVENTS

Management has evaluated subsequent eventspursuant tothe requirementsof ASCTopic 855and has determined thatno material subsequent events existother than those disclosed below.

OnApril 24, 2020,the Companyentered into a common stockrepurchase option agreement topurchase or assign 55,000shares of commonstock from a third partyat $0.05 pershare. The Company assigned its rightstothe repurchase optionagreement to athird party inexchange for compensation. Thecommonstockrepurchase option was exercised onApril 27, 2020for whichthe Companyreceived $19,250 in proceedswhich was recorded as additionalpaid-in capital.

Seenote8for additionalsubsequent events.


Item2. Management’s Discussion and Analysis Of Financial Condition And Results Of Operations

Thefollowing discussion and analysis of our financial conditionand results of operations should beread in conjunctionwith our consolidated financial statements and related notes included elsewhere in thisquarterlyreport. Thisdiscussion contains forward-looking statements,such as statements regarding the anticipated developmentand expansion of our business, our intent, belief or current expectations, primarilywith respect to thefutureoperating performance ofour companyandthe productsand services we expect to offerandother statements containedherein regarding matters thatarenot historical facts. Our Management’s Discussion and Analysis contains not only statements that are historical facts, butalso forward-looking statements which involverisks,uncertainties, and assumptions.Because forward-looking statements are inherently subject torisks and uncertainties, our actual results may differ materially from theresults discussed in the forward-lookingstatements.

Business Overview

We are afinancial technology companyutilizing innovative payment processing technologies to complementour coremerchant services capabilities.Our patentedand proprietarysoftware for merchant services, text marketingand lead generation arelicensable or availablethrough asuite of synergisticofferings directly toour clients. We are developing an enterprise-gradetext payment system usingthe simplicity andfamiliarity of textmessaging with multi-factor authentication to ensuresecurity.

Our company’s merchant services providefinancial processingfor businesses to accept traditionalmeansof cashlesspayments, such as credit cards,ACH, wireless payments, andmore. Through partnershipsand proprietarysoftware,we offerour merchants advanced capabilitiessuchasonline paymentgateways andpayment splitting to protect,enhance and expandtheir business.Further,in partthrough our intellectual property and patents,weoffer integrated,advanced solutionsfor mobilepayment processing, payment facilitation, digitalmarketing, software development,mobile appdevelopment, website development andwebsite hosting.

We areexpanding our merchant processing services to include enterprise-grade, patent protectedsoftware and intellectual propertyfor secureshort message system, or SMS, payments andadvanced text messaging for lead generation. Our patent protectedsoftware and technologymanages textmessaging for notification, response,authentication, marketing, advertising, information queriesand reports.Our software platformswill incorporate advancedintellectual property totransact mobile paymentsvia secure textmessaging based onsecure multi-factorauthentication, orMFA, technology, thereby extendingmerchants’ marketplaceand avenues toreceive payments.

We believethat our technologywill greatly increase the adoption ofmobile payment through ease of useincluding text-basedsecurityprotocols.Tosucceed, businesses mayneed to adopttext messaging to engagewiththeircustomers. We believethat our patent protectedtext platformwill allow businesses tocommunicate regularlywith their customers,suppliersand partnersknowing that theirtexts are being readand welcomed.

We seek to grow our business by pursuing the following strategies:

Increasing our customer base by offeringunique, patent protectedtechnologies;
Rolling-out oursecure text paymentsystemwhich does not require a data plan or anapplication;
Expandingour leadgeneration services enablingbusinesses to betterengage their customers;
Maintaining technologicalleadership by continuing toinnovate and improveour technology;
Pursuing strategic acquisitions or partnerships tocomplement and bolsterour suite of fintech products;
Creatingcross-selling synergiesby providing a holistic suite of productsandservices tomerchants;
Utilizinga scalable business model toeliminate certain barriers to rapidgrowth.


We are anOTCPink Open Market traded corporationheadquartered in Carlsbad,CA. Ourstock trades underthe symbol “APCX.” Wewerefounded in 1998 as Health ExpressUSA, Inc.Our business went throughname changesin 2005(CSI Business, Inc.), 2006(Natural NutritionInc.) and 2009 (AppTechCorp.) In 2013,wemerged with Transcendent One,Inc., whereby Transcendent One,Inc. and itsmanagementtook controllingownership of theCompany.From this pointforward,wehave operated as amerchant services provider,continuing the business conductedbyTranscendent One, Inc. In 2017,we acquired certain assets from GlobalTel Media,Inc., orGTM, which includedpatented, enterprise-gradesoftware for advanced text messaging. In addition tothe software and associated databases,the acquisition included four patentsand additionalintellectual propertyfor mobile payments andadvanced MFAsecurity protocols.

Effects of the COVID-19 Pandemic

Theunprecedented and adverseeffects of COVID-19,and its unpredictableduration, in theregions wherewehave merchants, employeesand consumershave had amaterial adverseeffect on our processingvolume and thus onour net revenuesand may inthe future have amaterial adverse effect onour liquidity andfinancial condition.

Financial Operations Overview

Thefollowing discussionsets forth certaincomponents of our statements of operationsaswellasfactors that impact those items.

Revenues

OurRevenues. We devise our revenue by providing financial processing services to businesses.

Expenses

Cost of Revenue. Cost of revenue includes costs directly attributable to processing and other services the company provides. These also include related costs such as residual payments to our business development partners, which are based on a percentage of the net revenue generated from client referrals.

General and administrative. General and administrative expenses include professional services, rent and utilities, and other operating costs.

Research and development. Research and development costs include costs of acquiring patents and other unproven technologies, contractor fees and other costs associated with the development of the SMS short code texting platform, contract and outside services.

Interest Expense, net. Our interest expense consists of interest on our outstanding indebtedness and amortization of debt issuance costs.

Results of Operations

This section includes a summary of our historical results of operations, followed by detailed comparisons of our results for the three-month periods ended March 31, 2020 and 2019, respectively. We have derived this data from our consolidated financial statements included elsewhere in this registration statement.


The Three Months Ended March 31, 2020

Compared to the Investor, andThree Months Ended March 31, 2019

Thefollowing table presents ourhistorical results of operationsfor the Investor purchased periods indicated:

  Three Months Ended March 31
(in thousands) 2020 2019
Revenue $58.2  $56.8 
Cost of revenue  23.2   22.5 
Gross profit  35.0   34.3 
         
Operating expenses        
General and administrative  1,415.9   189.7 
Research and development  12.0   6.8 
Total operating expenses  1,427.9   196.5 
Loss from operations  (1,392.9)  (162.2)
         
Other expenses        
Interest expense, net  71.1   76.0 
Total other expenses  71.1   76.0 
Loss before income taxes  (1,464.0)  (238.2)
         
Provision for income taxes        
Net Loss $(1,464.0) $(238.2)

Revenue

Revenue increased to $58,157 from $56,800, or 2%,for the threemonths ended March 31,2020from the threemonths ended March 31, 2019. Thisincrease was principally driven byvarious insignificant factors.

Cost of Revenue

Cost ofrevenue increased to $23,225from $22,537,or 3%,for the three months ended March 31, 2020from the Company,three months ended March 31,2019. Thisincrease was driven primarilyby various insignificantfactors.

General and Administrative Expenses

Generaland administrative expenses increased to $1,415,899 from $189,645,for the three months ended March31, 2020from the threemonths ended March31, 2019,primarily drivenbystock-based compensationdue toseveral significant consulting agreementsfor marketing and professional related services.

Research and Development Expenses

Research and development expenses increased to $12,000from $6,820, or76%, for the months ended March 31,2020 from thethree months ended March 31, 2019. Thisincreasewas primarily due tovarious insignificant factors.

Interest Expense, net

Interest expense, net decreased to$71,083 from $76,039, or 7%,for the three months ended March 31, 2020from the three months ended March 31, 2019. This decreasewas primarily drivenbythe elimination of one-time interest charges fortheamortization of the debtdiscounton new related party notespayable and refinancing charges on othernotespayable.


Liquidity and Capital Resources

While the companyiscontinuing operations and generating revenues,thecompany’s cash position isnot significant enough to supportthe company’s daily operations.Tothe extent that additionalfunds are necessary tofinanceoperationsand meet our long-termliquidityneeds as we continue toexecute our strategy,weanticipate that they can be obtainedthrough additionalindebtedness,equity or debtissuances or both.Usingcurrently available capitalresources, management believeswecanconduct planned operations for 21days. Further, management believesweneed to raise $1.35M toremain in businessfor the next 12months.

Sincewe deriveour revenues principally from processing ofpurchases fromour merchant services clients, a secured convertible promissory note (the “downturn ineconomic activity, such as thatNote”) in the principal amount of Nine Million Two Hundred Ninety-Two Thousand Eight Hundred Ninety-Four United States Dollars (US$9,292,894), the proceeds of which shall be used by the Company to finance the consideration paid by the Company to the Vendor in connectionassociated with the Purchase Agreement current coronavirus pandemic couldreduce the volume ofpurchaseswe process,and Assignment (as discussed herein above)thus our revenues. In addition,such adownturn could cause our merchant customers to cease operationspermanently decreasingour payment processing unless new customerswere found. We may alsoface additional difficulty in raising capitalduringan economicdownturn.

Cash Flows

Thefollowing table presents a summary of cashflows fromoperating, investing and financing activitiesfor other general corporate purposes.the following


The Note shall accrue interest at a rate equal to twelve percent (12%) per annum, except that comparative periods.

  Three Months Ended March 31,
  2020 2019
     
Net cash used in operating activities $(190,888) $(190,661)
Net cash provided by investing activities $23,411  $ 
Net cash provided by financing activities $158,481  $226,000 

Cash Flow from and afterOperating Activities

Netcash usedin operating activities increased by $227for the occurrence and duringthree months ended March 31, 2020from the continuance of an Event of Default (as defined in threemonths ended March31,2019. Thisincrease was principallydrivenby various insignificantfactors.

Cash Flow from Investing Activities

Netcash providedby investing activities increasedby $23,411for the Note),three months ended March 31, 2020from the interest rate shall be increased to eighteen percent (18%). The Note shall mature, unless extended months ended March31, 2019. Thisincrease was principallydrivenby the holder, upon the earlier of (i) June 1, 2012, (ii) the consummation arefund of a Changedepositand aprepayment of Control (as definedrent expense.

Cash Flow from Financing Activities

Netcash providedbyfinancing activities decreasedby $67,519for the three months ended March 31, 2020from themonths ended March31,2019. This decreasewas principallydriven by decreased proceeds fromthe sale of commonstock and proceedsfrom loans payable related parties.

Critical Accounting Policies

Our discussionand analysis ofour financial conditionand results of operations are based uponour financial statements, which have been prepared inaccordance with GAAP. The preparation ofthese financial statementsrequires us tomake estimates and judgmentsthat affect the Note)reportedamountsof assets, liabilities, revenuesand expenses.On anongoingbasis,weevaluate our estimatesincluding those related torevenue recognition, goodwill andintangible assets, derivativefinancial instruments, and (iii) the occurrence of an Event of Default or any eventequity-basedcompensation. We baseour estimates onhistorical experienceand onvarious other assumptions that with the passage of time and the failure to cure would result in an Event of Default. The Company may prepay the Note at any time upon not less than thirty (30) days prior written notice to the holder; provided, that any such prepayments shall applied first to unpaid late charges on principal and interest, if any, then to unpaid interest and then unpaid principal thereon. Furthermore, the Note shall be convertible into fully paid and nonassessable shares of the Company’s common stock, at the holder’s discretion, at a conversion rateare believed to be determined by dividing the amount to be converted by the lesser of (x) $0.04, subject to adjustment as provided herein and (y) eighty percent (80%) of the lowest daily weighted average price of the Company’s common stock during the five (5) trading days immediately preceding the conversion date. The Company shall not effect any conversion, and the holder of shall not have the right to convert any portion of the Note to the extent that after giving effect to such conversion, the holder (together with the holder’s affiliates) would beneficially own in excess of 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such conversion.


All payments duereasonable under the Note shall be senior to all other Indebtedness (as defined in the Note) of the Company and its subsidiaries other than certain Permitted Indebtedness (as defined in the Note). So long as the Note is outstanding, the Company shall not, and the Company shall not permit any of its subsidiaries to, directlycircumstances. Actual results maydiffer fromthese estimates underdifferent assumptions or indirectly (a) incur or guarantee, assume or suffer to exist any Indebtedness, other than (i) the Indebtedness evidenced by the Note and the Subsidiary Note and (ii) other Permitted Indebtedness, (b) allow or suffer to exist any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets (including accounts and contract rights) owned by the Company or any of its subsidiaries other than certain permitted liens, (c) redeem, defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part, whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Permitted Indebtedness, whether by way of payment in respect of principal of (or premium, if any) or interest on, such Indebtedness if at the time such payment is due or is otherwise made or, after giving effect to such payment: (i) an event constituting an Event of Default has occurred and is continuing; or (ii) an event that with the passage of time and without being cured would constitute an Event of Default has occurred and is continuing; or (iii) make any payments to Turnaround Partners, Inc. (“conditions.TAP”), Corporate Strategies, Inc. (“CSI”) or any of their members, partners, employees, stockholders, or any of their respective affiliates, except (1) with the prior consent of the holder, (2) pursuant to either the Zeidman Agreement (as defined herein below) or that certain Connolly Agreement (as defined herein below), (3) reasonable rent and overhead charges allocable to the Company in respect of shared space with CSI, (4) so long as Mr. Timothy J. Connolly (“Mr. Connolly”) is serving as CEO of the Company, the reimbursement to Mr. Connolly for all direct expenses incurred by Mr. Connolly in connection with such service and (5) payments by CSI-BF to Mr. Connolly for compensation payable to Mr. Connolly solely out of cash generated from CSI-BF’s operations.


Until

Critical accounting policiesarethose thatweconsider the most critical tounderstandingour financial condition andresults ofoperations.Theaccounting policieswe believe to bemost critical to understandingour financialcondition andresults of operations arediscussed below.As of March 31, 2020,there havebeenno significant changes toour criticalaccounting estimates, exceptas described in Note has2 toour consolidated financial statements.

Recent Accounting Pronouncements

As of March 31,2020,there have been converted, redeemedno significantchanges toour recentlyissued accounting pronouncements, except as described in Note 2 toour consolidated financial statements.

Off-BalanceSheet Arrangements

Wedo not have any relationshipswith unconsolidated entities or otherwise satisfiedfinancial partnerships, such as entitiesoften referred to asstructured finance or special purposeentities, that would have been established tofacilitate off-balancesheet arrangements (asthat term isdefined in fullItem303(a)(4)(ii) ofRegulationS-K) orother contractually narrow orlimited purposes. Assuch, we arenot exposed to anyfinancing, liquidity,market or creditrisk thatcould arise if wehad engaged in accordance with its terms, the Company shall not, directly or indirectly, redeem, repurchase, or declare or pay any cash dividend or distribution on, its capital stock without the prior express written consentthose types of the holder or, dissolve, liquidate, consolidate with orrelationships. Weenter into another person, or dispose of or otherwise transfer (whether in one transaction or in a series of transactions) all or substantially all of its assets (whether now owned or hereafter acquired) to or in favor of any person or acquire any assets or business or any interest in any person or entity in excess of One Hundred Thousand United States Dollars (US$100,000), except for purchases of inventory, raw materials and equipment guarantees in the ordinary course of business. So longbusiness related tothe guarantee ofour ownperformance.

Item 3. Quantitative and QualitativeDisclosuresAboutMarket Risk.

Not applicablefor smaller reporting companies.

Item 4. Control and Procedures.

Evaluation ofDisclosure Controls and Procedures

Underthe supervision andwith the participationofour management, includingthe Chief Executive Officerand the Chief Financial Officer,weevaluatedthe effectiveness of thedesignand operation ofour “disclosure controls and procedures” (asdefined inRule 13a-15(e)under the ExchangeAct) as ofthe Note is outstanding,end ofthe period covered by this report. Based onthat evaluation, the Chief ExecutiveOfficer and the Chief FinancialOfficerconcludedthat our disclosure controls andprocedures were effective asof March 31, 2020.

Changes in Internal Control over Financial Reporting

Therehave not beenany changes inour internal controlover financial reportingduringthe three-month periodended March 31, 2020that have materially affected, or arereasonably likely to materially affect,our internal controlover financial reporting.

Limitations on theEffectiveness of Controls

Control systems, no matter how well conceived and operated, aredesigned to provide areasonable, but notanabsolute, level ofassurance thatthe objectivesof the control system aremet. Further, the designof a control systemmust reflectthe fact thatthere areresource constraints, and the benefits of controlsmust beconsidered relative totheir costs. Because ofthe inherent limitationsin all controlsystems, no evaluationof controls can provideabsolute assurance that all control issuesand instancesoffraud, ifany, have been detected.Because of theinherent limitationsin any controlsystem, misstatements due to error orfraud may occur and not be detected.


PART II –OTHER INFORMATION

Item 1. Legal Proceedings

In September 2018, acomplaint was filed in San Diego SuperiorCourt for a breach ofcontract arising from asubsequent agreement regarding thepurchaseof ajudgment for the matter ofSvenstonBuelowand Amanda Eliotv. GlobalTel Media. Thepurchase of thejudgment was part of the transaction in whichweacquired our IPportfolio from GlobalTel Media. Wesubstantiallyperformed underthe original agreement,but the plaintiffs allegedwe breachedthe subsequent agreement whichwasexecuted toextend the finalpayment.On October 26, 2018,wefiled an answerthat denied each accounting period identifiedand every purported allegationand cause ofaction, furtherdeniedthat they caused anydamage orloss and assertedthe affirmative defense ofduress. We recorded as aliabilityas of December 31, 2019and2018 inthe amount of $135,000and $175,000,respectively. OnDecember3, 2019,thepartiesentered into aconditional settlementagreement wherebyweagreedto pay $150,000 on apayment schedule ending October1,2020.Should the repayment enterdefault withoutbeing cured,the court shall order an Exhibit toentry of judgment infavorof the Note,Plaintiffs inthe amount of $175,000 less any amounts paidunder the settlement, plus pre-judgment and post-judgment interest,courtcosts andreasonable attorneyfees.As ofMay 14, 2020,weare currently in default of the Company shall maintain EBITDA for such accounting period which equals or exceeds the applicable EBITDA threshold for such accounting period. The Company has beenagreement and are in discussions with the lender regardingplaintiffs to cure the interpretation of default by May 22, 2020.

In September 2018,the Exhibit to the Note as to whether it should be interpreted on landlordfor our former office space leasefiled a fiscal year or calendar year basis. An agreement on this issue has not yet been reached. On a strict calendar year basis as presentedlimitedcivil lawsuitagainst us in the ExhibitState ofCalifornia. Wereached an agreementthat resultedin a stipulationfor judgment on October 28,2018. Thestipulated judgmentwas for $42,432including attorneyfees andcourt costs plusinterest for whichwe recorded as aliability asof September 30, 2019and December 31,2018. Thestipulated judgment was paid infull onAugust 16,2019.

InNovember 2017,two shareholders of AppTech,onewho previouslyfiled a 2014lawsuitinthe StateofWashington, filed anotherlawsuit against us in the State ofCalifornia, claiming thesame accusations asthe previouslyfiled lawsuit which was dismissed. Thelawsuit has beentransferred tothe Note, our EBITDA United StatesDistrict Court for the 9Southern District of California. Wefiled an answer,affirmative defenses and counterclaims. Management believesthat the Plaintiffmisrepresented and mislead us during the merger between ourselves andTranscendent One,Inc. Thecourt has encouraged the parties tosettle. Even thoughthe Company believesthe lawsuit iswithout merit andwill vigorously defend,the Company hasmade several offers to settle. On December 19, 2019,the Company enteredinto a settlement andrelease agreement.The Company has recordedthe liability as ofDecember 31, 2019forthe total obligationof $240,000 to be paidout over three years beginning February 15, 2020. Astipulation for dismissalof action has beenfiled with the courts.Asof May 14, 2020,wearecurrent on thepayment schedule.

In March 2016, asignificant shareholder (“Plaintiff”) ofours filed alawsuit against usin thestate ofCalifornia alleging breachofcontract, fraudand negligent misrepresentation based onsupposed oralpromisesin 2013 togivePlaintiff’s company shares in exchange forstock in another company and a 2014consulting agreement. Westrongly disputed all claimsmade inthe lawsuit.OnApril 20, 2017,wefiledananswer that denied each and every purported allegationand cause ofactionand further deniedthat they caused anydamage orloss. Wereached anagreement resulting in a voluntary dismissalofthe civil case on July 5, 2017. ThePlaintiff was not able tofulfill the proper documentationwithin the allotted 180days and the 3,450,000shares ofour commonstock were properly cancelled in 2019.

Item 1A. Risk Factors.

As asmaller reportingcompany, as defined inRule12b-2 ofthe ExchangeAct,we are not required toprovide the information required by this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

During 2020year-to-date,weassigned ourrights tostock repurchase optionagreements to third partiesresulting innet proceeds of $205,781.

Duringthethree months ended September 30, 2008 was CDN$1,392,119 versus CDN$1,387,238 as required under the Exhibit to the Note.


9


March 31, 2020, 2,349,500In connection with the SPA, the Company also issued to the Investor warrants to purchase, in Investor’s sole discretion, Seventy-Eight Million One Hundred Thirty-Five Thousand Two Hundred Twenty-Four (78,135,224) sharesof common stockwere issued toseveralconsultants in connectionwith business developmentand professional services renderedvalued at a price$1,209,185.Duringthethree months ended March 31, 2020, weassignedourrights to stockrepurchase option agreements to third partiesresulting innetproceeds of $0.008 per share (the “$186,531.During the threemonthsended March 31, 2020,no sharesWarrantof common stock wereissued tothe managementormembers”). So long as ofthe Company is in default under anyBoard ofDirectors.

All Issuances were exempt from registration requirements of the Transaction Documents (as defined in the SPA) or the shares underlying the Warrant are not subject to an effective registration statement, the holder may, in its sole discretion during such time, exercise the Warrant in whole or in part and, in lieuSection 5 of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise Price (as defined in the Warrant), elect instead to receive upon such exercise the net number of shares of Common Stock determined according to a specified formula set forth in the Warrant. The Company shall not effect the exercise of the Warrant, and the holder shall not have the right to exercise the Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates) would beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after giving effect to such exercise.


Contemporaneously with the execution and delivery of the SPA, the Company and the Investor executed and delivered a registration rights agreement (the “RRA”) pursuant to which the Company shall provide certain registration rights to Investor with respect to the Registrable Securities (as defined in the RRA) under the Securities Act of 1933 as amendedthey did not involve a public offering under Section 4(a)2(2) and the rules and regulations promulgated thereunder, and applicable statewere issued as restricted securities laws. Specifically, if the Company shall receive at any time and from time to time after the aggregate principal amountasdefinedinRule 144 of the Note is below One Million Five Hundred Thousand United States Dollars (US$1,500,000)Act.


Item 3.Defaults Upon Senior Securities.

All subordinated notes payable,convertible notespayable andnotes payableare currently in whatever form, including without limitation, the reduction of the outstanding balance by conversions by the Investor into shares of Common Stock or cash payments by the Company, a written request from the holders of at least fifty percent (50%) of the Registrable Securities then outstanding, that the Company file with the SEC a registration statement covering the resale of the Registrable Securities, then the Company shall, within thirty (30) days of the receipt thereof, provide written notice of such request to all other holders of Registrable Securities, if any, and file with the SEC such registration statement, as soon as practicable, following receipt of the registration request. The registration statement shall register for resale at least thirty-three percent (33%) of the Company’s market capitalization based on the Company’s shares of Common Stock issued and outstanding and market price of the Company’s shares of Common Stock at the time of the registration request less any shares of Common Stock held by affiliates of the Company, or such greater amount as the Company in good faith believes the SEC may permit to be registered. The Company shall use its best efforts to have the registration statement declared effective by the SEC no later than such date as follows: (i) in the event that the registration statement is not subject to a review by the SEC, sixty (60) calendar days after the date of the registration request or (ii) in the event that the registration statement is subject to a review by the SEC, one hundred twenty (120) calendar days after the date of the registration request.default.


Item 4.In connection with the SPA, the Company and the Investor also entered into an amended and restated security agreement, of even date with the SPA (the “Mine Safety Disclosures.

Not Applicable.

Item 5.2007 Security AgreementOther Information.

None.

Item 6.”), pursuant to which the Company amended and restated that certain Security Agreement, dated September 9, 2005 (the “Exhibits.

EXHIBIT2005 Security AgreementINDEX”), to secure within the definition of “Obligations” as previously defined under the 2005 Security Agreement, those obligations of the Company under the SPA, the Note and the Transaction Documents (as defined in the SPA). The Company and the Investor also entered into a securities pledge agreement, of even date with the SPA (the “2007 Pledge Agreement”), in order for the Company to pledge that certain Pledged Property (as defined therein), which includes the Subsidiary Note, to secure its obligations under the SPA, the Note and the Transaction Documents (as defined in the SPA).

In connection with the SPA, the Company, the Investor and Mr. Timothy J. Connolly, acting on behalf of CSI, entered into an agreement, of even date with the SPA (the “Connolly Agreement”), pursuant to which the Company granted to Mr. Connolly, on behalf of CSI, shares representing ten percent (10%) of the common stock of INII (the “INII Stock”) outstanding as of the date of the Agreement as compensation for management services performed by CSI to the Company. Such grant vested and the INII Stock has been deemed fully earned as of the date of the Agreement. As a condition to this grant, Mr. Connolly entered into a lock-up agreement and a securities pledge agreement with the Investor, whereby Mr. Connolly pledged the INII Stock as collateral to secure all obligations owed by the Company to the Investor. Effective as of December 31, 2007, the Company entered into a Purchase Agreement with Corporate Strategies, Inc. (Seller) and CSI Business Finance, Inc. pursuant to which the Seller conveyed, transferred and assigned to the Company all of its title to and rights in Seller’s ten percent (10%) interest in the total issued and outstanding capital stock of INII in exchange for the conveyance, transfer and assignment to the Seller by the CSI Business Finance, Inc. and the Company of certain Notes held by CSI Business Finance, Inc. and the Company plus a cash payment equal to One Hundred Ninety-Eight Thousand Eight Hundred Ninety-Nine Dollars and Ten Cents ($198,899.10). In addition, the Company assumed payment for all of the Seller’s office lease, equipment payments and any other payments related to the office space at 109 N. Post Oak Lane, Suite 422, Houston, Texas 77024 for the remainder of the lease term and any renewals.

In connection with the SPA, the Company entered into a five (5) year employment agreement with Mr. Fred Zeidman pursuant to which Mr. Zeidman shall serve as a non-executive Chairman of the Board (the “Zeidman Agreement”). In consideration for his services, Mr. Zeidman shall receive, as compensation for all services rendered by Mr. Zeidman in performance of his duties or obligations under the Zeidman Agreement, a monthly base salary of Twelve Thousand Five Hundred United States Dollars (US$12,500). In addition to a base salary, Mr. Zeidman shall also have the right to receive an incentive fee equal to up to ten percent (10%) of the Net Proceeds (as defined therein) of the Sale (as defined therein) of INII. This bonus shall incrementally vest twenty percent (20%) per year on the anniversary date of the Zeidman Agreement, so long as (A) Mr. Zeidman’s employment with the Company has not terminated as of the applicable vesting date and (B) the actual financial results of INII for the twelve (12) month period prior to the applicable vesting date are not less than ninety percent (90%) of the pro forma EBITDA results of INII attached to the Zeidman Agreement as Exhibit A; provided that upon a Sale prior to the fifth (5th) anniversary of the commencement date, so long as Mr. Zeidman’s employment has not terminated prior to such Sale, then the remaining part of the bonus shall vest upon the consummation of such Sale. Mr. Zeidman is also entitled to be reimbursed by the Company for all reasonable and necessary expenses incurred by Mr. Zeidman in carrying out his duties under the Zeidman Agreement in accordance with the Company’s standard policies regarding such reimbursements. Mr. Zeidman is also entitled during the term of the Zeidman Agreement, upon satisfaction of all eligibility requirements, if any, to participate in all health, dental, disability, life insurance and other benefit programs now or hereafter established by the Company which cover substantially all other of the Company’s employees and shall receive such other benefits as may be approved from time to time by the Company.

10

Since the acquisition was completed on May 31, 2007, only the period from June 1 through September 30, 2007 is included in our nine months results of operations ending September 30, 2007.

The following unaudited pro forma financial information presents the consolidated results of operations for the three and nine months ended September 30, 2008, as if the acquisition had occurred on January 1, 2007, after giving effect to certain adjustments. The pro forma information does not necessarily reflect the results of operations that would have occurred had the entities been a single company during this period.
  Three months ended September 30,
 
Nine months ended September 30,
 
 
 
2008
 
2007
 
2008
 
2007
 
 
 
(Unaudited)
 
(Unaudited)
 
(Unaudited)
 
(Unaudited) 
          
Net sales $3,978,246 $4,247,022 $12,338,891 $12,866,026 
Net income (loss) $(1,842,182)$(358,367)$3,124,441 $(5,445,645)
Weighted shares outstanding - basic  66,104,072  19,259,139  49,855,367  16,060,568 
Weighted shares outstanding - diluted  154,924,622  2,209,918,984  145,965,917  2,206,720,413 
Net income (loss) per share - basic $(0.03)$(0.02)$0.06 $(0.34)
Net income (loss) per share - diluted $(0.01)$(0.02)$0.02 $(0.00)

NOTE 4 - CONVERTIBLE DEBENTURES AND NOTES PAYABLE AND DERIVATIVE FINANCIAL INSTRUMENTS
Effective September 9, 2005, the Company issued a secured convertible debenture (the "Debenture") to the Investor in the amount of $15,635,199. Effective May 31, 2007, the convertible debenture was renegotiated and the due date was extended until June 1, 2012 and the fixed conversion price was reset. All other terms and conditions remained the same. The notes bear interest at 5%, which is accrued until maturity on June 1, 2012. The note is convertible, at the option of the holders, into common stock of the Company at a price of $0.0096 per share, subject to standard anti-dilution provisions relating to splits, reverse splits and other transactions plus a reset provision whereby the conversion prices may be adjusted downward to a lower price per share based on the average of the three lowest closing prices for the five trading days prior to conversion. The Holder has the right to cause the notes to be converted into common stock, subject to an ownership limitation of 4.99% of the outstanding stock. The Company has the right to repurchase the Notes at 106% of the face amount.

On May 31, 2007, the Company entered into a securities purchase agreement (the “SPA”) with the Investor pursuant to which the Company sold to the Investor, and the Investor purchased from the Company, a secured convertible promissory note (the “Note”) in the principal amount of Nine Million Two Hundred Ninety-Two Thousand Eight Hundred Ninety-Four United States Dollars (US$9,292,894), the proceeds of which shall be used by the Company to finance the consideration paid by the Company to the Vendor in connection with the Purchase Agreement and Assignment (as discussed herein above) and for other general corporate purposes.

The Note shall accrue interest at a rate equal to twelve percent (12%) per annum, except that from and after the occurrence and during the continuance of an Event of Default (as defined in the Note), the interest rate shall be increased to eighteen percent (18%). The Note shall mature, unless extended by the holder, upon the earlier of (i) June 1, 2012, (ii) the consummation of a Change of Control (as defined in the Note) and (iii) the occurrence of an Event of Default or any event that with the passage of time and the failure to cure would result in an Event of Default. The Company may prepay the Note at any time upon not less than thirty (30) days prior written notice to the holder; provided, that any such prepayments shall applied first to unpaid late charges on principal and interest, if any, then to unpaid interest and then unpaid principal thereon. Furthermore, the Note shall be convertible into fully paid and nonassessable shares of the Company’s common stock, at the holder’s discretion, at a conversion rate to be determined by dividing the amount to be converted by the lesser of (x) $0.04, subject to adjustment as provided herein and (y) eighty percent (80%) of the lowest daily weighted average price of the Company’s common stock during the five (5) trading days immediately preceding the conversion date. The Company shall not effect any conversion, and the holder of shall not have the right to convert any portion of the Note to the extent that after giving effect to such conversion, the holder (together with the holder’s affiliates) would beneficially own in excess of 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such conversion.

11

The derivatives from the debenture and note payable have been accounted for in accordance with SFAS 133 and EITF No. 00-19, "Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company's Own Stock."

The Company has determined that the following instruments have derivatives requiring evaluation and accounting under the relevant guidance applicable to financial derivatives:

Exhibit Cornell Debenture Payable issued 9/9/05 inExhibit
NumberTitle
3.1AppTechCorp.Articlesof Conversion filed October 25, 2006 (filed as Exhibit 3.1 to the face amount of $15,635,199Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
  Cornell Note Payable issued 5/31/07 in the face amount of $9,292,894

The Company has identified that the above debenture and note have embedded derivatives. These embedded derivatives have been bifurcated from their respective host debt contracts and accounted for as derivative liabilities in accordance with EITF 00-19. When multiple derivatives exist within the Convertible Debentures, they have been bundled together as a single hybrid compound instrument in accordance with SFAS No. 133 Derivatives Implementation Group Implementation Issue No. B-15, "Embedded Derivatives: Separate Accounting for Multiple Derivative Features Embedded in a Single Hybrid Instrument."
The embedded derivatives within the Convertible Debenture and Note have been recorded at fair value at the date of issuance; and are marked-to-market each reporting period with changes in fair value recorded to the Company's income statement as "Net change in fair value of derivatives." The Company has utilized a third party valuation firm to fair value the embedded derivatives using a layered discounted probability-weighted cash flow approach. The fair value model utilized to value the various embedded derivatives in the Convertible Debenture and Note, comprises multiple probability-weighted scenarios under various assumptions reflecting the economics of the Convertible Debenture, such as the risk-free interest rate, expected Issuer stock price and volatility, likelihood of conversion and or redemption, and likelihood default status.

The fair value of the derivative liabilities are subject to the changes in the trading value of the Company's common stock, as well as other factors. As a result, the Company's financial statements may fluctuate from quarter-to-quarter based on factors, such as the price of the Company's stock at the balance sheet date and the amount of shares converted by the debenture holders. Consequently, our financial position and results of operations may vary from quarter-to-quarter based on conditions other than our operating revenues and expenses.

The conversion feature, reset provision and the Company’s optional early redemption right to the debenture payable have been bundled together as a single compound embedded derivative liability, and using a layered discounted probability-weighted cash flow approach, was initially fair valued at $413,603 at September 9, 2005. As of May 31, 2007, the maturity date of the Investor debenture dated September 9, 2005 was extended to June 1, 2012 and the fixed conversion price was reset to $0.0096. This modification of the debt was tested under EITF 96-19, Debtors Accounting for a Modification or Exchange of Debt Instruments and EITF 06-06, Debtors Accounting for a Modification (or Exchange) of Convertible Debt Instruments to determine if an extinguishment had occurred. The Company’s third party valuation firm determined that the debt was not extinguished, so no gain or loss was recorded. The compound embedded derivative was valued at $3,583,192 at September 30, 2008 using the same methodology. For the period since December 31, 2007 through September 30, 2008, the change in fair value of the derivative liability was a decrease of $1,160,186, which has been classified as net change in fair value of derivative.

The above compound embedded derivative plus the loan costs paid the lender in the amount of $687,832 are recorded as a discount against the notional carrying amount of the debenture payable. The unamortized discount is being amortized over the term of the note using the effective interest method. Recorded in interest expense for this amortization is $25,840 at September 30, 2008 and $169,955 at September 30, 2007.

The conversion feature, reset provision and the Company’s optional early redemption right to the note payable have been bundled together as a single compound embedded derivative liability, and using a layered discounted probability-weighted cash flow approach, was initially fair valued at $554,080 at May 31, 2007. Using the same methodology, the single compound embedded derivative liability was valued at $1,540,064 at September 30, 2008. For the period since December 31, 2007 through September 30, 2008, the change in fair value of the derivative liability was a decrease of $2,770,894, which has been classified as net change in fair value of derivative.

In addition to the above, the Company issued warrants that resulted in a warrant derivative liability. This warrant derivative liability using the Black-Sholes Option Pricing Model was initially fair valued at $626,790 at May 31, 2007. Using the same methodology, the warrant derivative liability was valued at $682,698 at September 30, 2008. For the period since December 31, 2007 through September 30, 2008, the change in fair value of the derivative liability was a decrease of $2,447,742, which has been classified as net change in fair value of derivative. The significant assumptions for the Black-Sholes Option Pricing Model at September 30, 2008 was the current stock price, 0% dividend yield, a risk free interest rate of 3.38% and a 250% volatility.

12

The above compound embedded derivative plus the warrant derivative plus the loan costs paid the lender in the amount of $1,004,289 are recorded as a discount against the notional carrying amount of the note payable. The unamortized discount is being amortized over the term of the note using the effective interest method. Recorded in interest expense for this amortization is $323,152 at September 30, 2008 and $141,913 at September 30, 2007.

The significant assumptions for the Company’s debenture and note utilized in valuing the embedded derivatives as of September 30, 2008:

-  The stock price would increase at the cost of equity with a short-term volatility of 240%
-  Registration default would occur only 5% of the time
-  Other forms of default would occur 5% of the time, increasing .3% per quarter
-  Alternative financing would be available starting at 0%, increasing 5% per quarter to a maximum of 20%
-  Common Shares outstanding would increase 5% per quarter
-  Exercise pricing reset events would occur 5% of the time with an adjustment factor to the warrant exercise price of 0.9989
-  Quarterly conversions of the debentures would be limited to the lesser of 4.99% of the outstanding stock or 25% of the average 22-day trading volume.
NOTE 5 - SEGMENT REPORTING

Our Company has two business segments: business services (which consist of lending services) and manufacturing and sales of nutritional products through our wholly owned subsidiary, INII. The Company intends to wind down the business services segment as these assets are monetized and devote these resources to expanding the international marketing, sales, and distribution of the Company’s nutritional products.

The Company's operations are conducted in the United States and Ottawa, Ontario, Canada.
 
 
Business
 
Nutritional
 
 
 
Services
 
Products
 
      
Nine months ended September 30, 2008
     
Revenue $57,683 $12,281,208 
Interest expense  818,094  991,773 
Income (loss) before income tax  3,491,612  (435,971)
Income tax benefit  -  (68,800)
Segment assets  9,195,654  11,824,809 
Additions to long-term assets  109,122  38,269 
Depreciation and amortization  5,904  623,608 
        
Nine months ended September 30, 2007
       
Revenue $222,186 $5,771,105 
Interest expense  656,256  622,937 
Loss before income tax  (4,855,073) (143,366)
Income tax benefit  -  (59,442)
Segment assets  3,723,371  21,150,287 
Additions to long-term assets  -  95,223 
Depreciation and amortization  2,271  278,929 

13

NOTE 6 - RELATED PARTY TRANSACTIONS

Turnaround Partners, Inc. (f/k/a Emerge Capital Corp.) and the Company are separate public entities that were previously under common control. On December 5, 2007, a new majority shareholder invested in Turnaround Partners, Inc. At that time, Timothy J. Connolly and Fred Zeidman resigned as officers and directors and Turnaround Partners, Inc. is no longer affiliated with Natural Nutrition, Inc.

Brokerage fees

Corporate Strategies, Inc. previously had an arrangement whereby it introduced prospective financing clients to the Company. If a transaction was consummated, Corporate Strategies, Inc. earned a fee from the borrower. For the quarters ended September 30, 2008 and 2007 such fees have totaled $-0- and $2,965, respectively. No fees are paid to Corporate Strategies, Inc. by the Company since they are paid by the borrower. No further fees are expected to be paid as the Company is no longer in the business of lending.

Allocation of operating expenses

Corporate Strategies, Inc., a wholly owned subsidiary of Turnaround Partners, Inc, previously performed certain administrative and management functions for the Company. Based on an estimation of efforts expended, the Company was allocated $-0- and $199,835 for the nine months ended September 30, 2008 and 2007, respectively. Corporate Strategies, Inc. no longer provides these functions for the Company.

NOTE 7 - COMMON AND PREFERRED STOCK

During the first nine months of this year, we have issued 39,888,848 new shares of common stock. We issued 3,011,385 shares for the conversion of preferred stock into common stock, 7,689,285 shares as a result of the 5 for 4 stock split approved on January 28, 2008, 24,188,178 shares for the conversion of convertible debentures and 5,000,000 shares for services.

In May 2007 the Company granted the CEO super voting rights in consideration for the CEO entering into a Lockup Agreement for so long as he continues to serve as CEO, preventing him from selling shares of the Company until all amounts owed to the Investor have been fully paid. The Board of Directors approved the designation of Series B convertible preferred stock, par value $.001 to be issued to the CEO which have substantially the same powers and other special rights as the Series A preferred stock except that such new shares shall include super voting rights. Each share of the Series B convertible preferred stock is convertible into 975 shares of common stock. The holders of Series B preferred stock and the holders of common stock shall vote together and not as separate classes, and the Series B preferred stock shall be counted on an “as converted” basis multiplied by One Hundred (100). The transaction converting the CEO’s 71,455 Series A preferred stock to Series B preferred stock was completed during the quarter ended September 30, 2008.
14

MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.
FORWARD-LOOKING STATEMENTS AND ASSOCIATED RISKS

This Quarterly Report on Form 10-QSB, and the accompanying MD&A, contains forward-looking statements.  Statements contained in this report about Natural Nutrition, Inc.'s future outlook, prospects, strategies and plans, and about industry conditions and demand for our financial services are forward-looking.  All statements that express belief, expectation, estimates or intentions, as well as those that are not statements of historical fact, are forward looking. The words "proposed," "anticipates," "anticipated," "will," "would," "should," "estimates" and similar expressions are intended to identify forward-looking statements.  Forward-looking statements represent our reasonable belief and are based on our current expectations and assumptions with respect to future events. While we believe our expectations and assumptions are reasonable, they involve risks and uncertainties beyond our control that could cause the actual results or outcome to differ materially from the expected results or outcome reflected in our forward-looking statements.  In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this quarterly report may not occur.  Such risks and uncertainties include, without limitation, our successful efforts in the outcome of our litigation concerning our investment in INII, or the extension of our agreement in lieu of foreclosure, our success in trading marketable securities, our ability to maintain contracts that are critical to our operations, actual customer demand for our financing and related services, collection of accounts and notes receivable, our ability to obtain and maintain normal terms with our vendors and service providers and conditions in the capital markets and equity markets during the periods covered by the forward-looking statements. 

The forward-looking statements contained in this report speak only as of the date hereof.  We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or any other reason.  All forward-looking statements attributable to Natural Nutrition, Inc. or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in our Form 10-KSB and in our future periodic reports filed with the SEC. The following M,D&A should be read in conjunction with these unaudited Consolidated Financial Statements of the Company, and the related notes thereto included elsewhere herein, and in conjunction with our audited financial statements, together with footnotes and the MD&A, in our 2007 annual report filed on Form 10-KSB with the SEC.

Overview
On August 25, 2005, Health Express USA, Inc., a Florida corporation, entered into a share exchange agreement with CSI-BF and CSI, the stockholder of CSI-BF. The transaction is being reflected as a reverse acquisition since control of the Company has passed to the shareholders of CSI. The Company was subsequently renamed in 2005 to CSI Business Finance, Inc. (the Florida corporation). In September of 2006, we changed our name from CSI Business Finance, Inc. to Natural Nutrition, Inc. and simultaneously migrated from Florida to Nevada.

On May 23, 2006, our Board of Directors approved a 1 for 25 reverse split of our Common Stock. On January 29, 2008, our Board of Directors approved a 5 for 4 forward common stock split. All references to our common stock in this document are stated in shares after the forward stock split.

All significant intercompany accounts and transactions have been eliminated in consolidation.

Prior to and during a part of 2007, our Company, through our wholly-owned operating subsidiary, CSI Business Finance, Inc., primarily generated cash and revenue from financing and investing activities. These activities included equipment leasing, factoring and loan brokerage activities earned in originating and selling business leases, providing short term secured lending, and investing in marketable securities. Management of the Company mitigates its risk in lending by securing loans with pledged assets (collateral) that, when liquidated, have a reasonable probability of realizing proceeds that would retire the liability. In some instances, we obtain personal guarantees from individuals of net worth which are adequate to repay the liability in the event of default. We also traded marketable securities and options with available cash, and on margin. Because our trading involved leveraging, these transactions contained a considerable amount of risk. These activities and all new lending activities of CSI-BF were discontinued in 2007 following the settlement of the litigation and acquisition of the senior debt and operations of INII. 

Our management will now concentrate its efforts on collecting the remaining notes receivable from CSI-BF’s former operations. CSI-BF was renamed iNutrition Inc. and is currently the marketing arm of INII. CSI-BF’s mission is to grow the “direct to consumer” sales program for the INII sports nutrition and dietary supplement products. The core focus of all operations is now based on growing the business of INII, our largest asset, which was acquired pursuant to that certain agreement in lieu of foreclosure of a note purchased by the Company in March 2006. INII, a wholly-owned subsidiary of Natural Nutrition, Inc. (OTC Bulletin Board: NTNI), is a twelve (12) year-old specialty manufacturer of sports, nutritional and natural dietary supplement products. INII is an international leader in dietary supplements backed by over twelve (12) years of research and development. INII is authorized to sell sports nutrition products in over eighteen (18) countries throughout the world. All products are manufactured under strict Canadian government quality control measures.

15

Effective May 31, 2007, we closed on the Purchase Agreement with the Vendor pursuant to which the Company purchased from the Vendor, and the Vendor sold, assigned transferred and conveyed to the Company, certain Indebtedness owed to the Vendor by INII under that certain Subsidiary Note in the original principal amount of Fifteen Million Canadian Dollars (Cdn$15,000,000) issued (in part) by INII to the Vendor on March 31, 2004 and (b) a general security agreement, of even date with the Subsidiary Note, and a share pledge agreement, of even date with the Subsidiary Note, both granted concurrently by INII and its shareholder, the Company (as successor in interest to the now defunct Bio-One) in connection with the Indebtedness (together, both instruments are hereinafter referred to as the “Security”) for a purchase price equal to (i) Seven Million Six Hundred Fifty Thousand Canadian Dollars (Cdn$7,650,000) and (ii) the execution by the Company of that certain Mutual Release.  The Company and the Vendor entered into that certain Assignment, of even date with the Purchase Agreement, in order to properly effectuate the assignment by the Vendor to the Company of all of the right, title, benefit and interest in and to the Purchased Assets (as defined therein), which such Purchased Assets include, without limitation, the Indebtedness, the Security and all loan, security and other documentation relating to the Indebtedness and the Security purchased under the Purchase Agreement.  The Company and the Vendor executed the Purchase Agreement, the Mutual Release and the Assignment on May 25, 2007; however, the parties closed the transactions upon the execution of the SPA on May 31, 2007.
Recent Accounting Pronouncements

In March 2008, the FASB issued Statement No. 161, Disclosures about Derivative Instruments and Hedging Activities - an amendment of FASB Statement No. 133 (SFAS 161). This statement requires enhanced disclosures about an entity’s derivative and hedging activities and is effective for financial statements issued for fiscal years and interim periods beginning after November 15, 2008, with earlier application encouraged. The Company will adopt SFAS 161 in the first fiscal quarter of 2009. Since SFAS 161 requires only additional disclosures concerning derivatives and hedging activities, adoption of SFAS 161 will not have an impact on the Company’s consolidated financial condition, results of operations or cash flows.

RESULTS OF OPERATIONS

Three Months Ended September 30, 2008 and September 30, 2007

INII was acquired by us on May 31, 2007.

Sales revenue for the three months ended September 30, 2008 included sales for INII of $3,910,138 as compared to $4,201,764 for the three months ended September 30, 2007. This revenue was generated from sales of nutritional products from INII.

Interest Income was $49,249 for the three months ended September 30, 2008 as compared to $52,826 for the three months ended September 30, 2007. Interest income was derived mainly from notes receivable relating to investments. Dividend income was $7,332 for the three months ended September 30, 2008 and $546 for the three months ended September 30, 2007. Dividend income is primarily derived from various investments in marketable securities. For the three months ended September 30, 2008, we recorded net trading gains from various investments in marketable securities in the amount of $11,527 as compared to losses of $8,114 for the three months ended September 30, 2007. The gains in the 2008 period are primarily a result of mark-to-market adjustments at September 30, 2008. We intend to wind down these activities and make the primary focus of management as well as devoting the Company’s resources to expanding the international marketing, sales and distribution or INII’s nutritional products.

Cost of goods sold, selling, general and administrative expenses and other income and expenses

INII

Cost of sales for our revenue in INII was $3,173,853 for the three months ended September 30, 2008 as compared to $3,467,897 for the three months ended September 30, 2007. Cost of sales includes material, labor and manufacturing costs associated with the production of our products.

Selling, general and administrative expenses were $517,793 for the three months ended September 30, 2008 as compared to $513,954 for the three months ended September 30, 2007. These expenses include salaries and benefits, professional fees and other ordinary expenses necessary to carry out our operations.

Houston Operations

Our Houston operating expenses were approximately $1,324,396 for the three months ended September 30, 2008 as compared to $638,739 for three months ended September 30, 2007.Approximately $925,000 of the total expenses in 2008 relates to bad debt expense on notes receivable as compared to $447,377 for the three months ended September 30, 2007.

16


Salaries and Benefits were $160,964 for the three months ended September 30, 2008ascompared to $134,742 for the three months ended September 30, 2007.The primary reason for the increase was the allocation of manpower due to the acquisition of INII in May 2007 including the assignment of a full time executive assistant to the Company.
Professional fees were $108,951 for the three months ended September 30, 2008as compared to $20,475 for the same period ending September 30, 2007.The primary reason for the increase is consulting fees paid in 2008 for internet marketing consulting.
Interest expense was $484,074 for the three months ended September 30, 2008and $475,729 for the three months ended September 30, 2007.Interest expense primarily relates to the expense associated with the $15,635,199 five percent (5%) convertible debenture entered into in September 2005 and interest on our May 31, 2007 note.

The Company was allocated overhead from a former affiliate in the amount of $-0- for the three months ended September 30, 2008, as compared to $50,114 for the three months ended September 30, 2007. The expenses included rent, office supplies, travel and other ordinary expenses necessary to carry out our corporate operations. The arrangement with the former affiliate was discontinued at the end of 2007 due to a change in ownership of the former affiliate.

We recorded expenses of $104,024 for the net change in fair value of our derivatives associated with our convertible debenture and note.

Nine Months Ended September 30, 2008 and September 30, 2007

INII was acquired by us on May 31, 2007.

Sales revenue for the nine months ended September 30, 2008 included sales for INII of $12,264,672 as compared to $5,771,105 for the nine months ended September 30, 2007. Revenue for 2007 included INII operations for the four months ended September 30, 2007. This revenue was generated from sales of nutritional products from INII.

Fee income from brokerage fees earned in originating and selling business leases and loans was $0 for the nine months ended September 30, 2008 versus $2,965 for the nine months ended September 30, 2007. We intend to wind down this activity and make the primary focus of management as well as devoting the Company’s resources to expanding the international marketing, sales and distribution of INII’s nutritional products.

Interest Income was $167,462 for the nine months ended September 30, 2008 as compared to $206,309 for the nine months ended September 30, 2007. Interest income was derived mainly from notes receivable relating to investments. Dividend income was $36,257 for the nine months ended September 30, 2008 and $9,015 for the nine months ended September 30, 2007. Dividend income is primarily derived from various investments in marketable securities. For the nine months ended September 30, 2008, we recorded net trading losses from various investments in marketable securities in the amount of $129,500 as compared to gains of $3,897 for the nine months ended September 30, 2008. The losses in 2008 were primarily attributable to losses relating to the auction rate securities discussed below. We intend to wind down these activities and make the primary focus of management as well as devoting the Company’s resources to expanding the international marketing, sales and distribution of INII’s nutritional products.

Cost of goods sold, selling, general and administrative expenses and other income and expenses

INII

Cost of sales for our revenue in INII was $9,790,380 for the nine months ended September 30, 2008 as compared to $4,767,414 for the nine months ended September 30, 2007 which included only four months after the acquisition of INII on May 31, 2007. Cost of sales includes material, labor and manufacturing costs associated with the production of our products.

Selling, general and administrative expenses were $1,654,192 for the nine months ended September 30, 2008 as compared to $647,057 for the nine months ended September 30, 2007. These expenses include salaries and benefits, professional fees and other ordinary expenses necessary to carry out our operations.

Houston Operations

Our Houston operating expenses were approximately $2,118,777 for the nine months ended September 30, 2008 as compared to $2,770,730 for nine months ended September 30, 2007.

Salaries and Benefits were $498,261 for the nine months ended September 30, 2008ascompared to $412,405 for the nine months ended September 30, 2007.The primary reason for the increase was the allocation of manpower due to the acquisition of INII in May 2007 including the assignment of a full time executive assistant to the Company.
17

Professional fees were $347,141 for the nine months ended September 30, 2008as compared to $1,154,218 for the same period ending September 30, 2007.The primary reason for the decrease is an approximate $890,000 one-time fee paid to a former affiliate for past services rendered for control of INII in 2007.

Interest expense was $1,430,541 for the nine months ended September 30, 2008and $956,344 for the nine months ended September 30, 2007.Interest expense primarily relates to the expense associated with the $15,635,199 five percent (5%) convertible debenture entered into in September 2005 and four month’s interest in 2007 on our May 31, 2007 note.

The Company was allocated overhead from a former affiliate in the amount of $-0- for the nine months ended September 30, 2008, as compared to $199,835 for the nine months ended September 30, 2007. The expenses included rent, office supplies, travel and other ordinary expenses necessary to carry out our corporate operations. The arrangement with a former affiliate was discontinued at the end of 2007 due to a change in ownership of the former affiliate.

We recorded income of $6,389,641 for the net change in fair value of our derivatives associated with our convertible debenture and note.

Liquidity and Capital Resources

Operating Activities 

We recorded net income for the nine months ended September 30, 2008 in the amount of $3,124,441. During the nine months ended September 30, 2008, our operations used cash in the amount of $245,527. Cash used by operating activities was primarily due to increases in accounts receivable, inventory and prepaid expenses, offset by increases in accounts payable and accrued liabilities. Cash also increased as a result of reductions in investments in marketable securities.

Investing Activities

We used cash totaling $147,391 for the acquisition of fixed assets during the nine months ended September 30, 2008.

As of September 30, 2008, we had approximately $1,680,000 in cash and short-term investments. We believe the working capital available to us will be sufficient to meet our cash requirements for at least the next 12 months.

Financing Activities

We used cash totaling $47,606 for payment on capital lease obligations during the nine months ended September 30, 2008. The Company’s secured convertible promissory note in the amount of $9,292,894 requires that the Company maintain EBITDA for each accounting period which equals or exceeds the applicable EBITDA threshold for such accounting period. Our EBITDA for nine months ended September 30, 2008 was CDN$1,392,119 versus CDN$1,387,238 as required under the Exhibit to the Note for the nine months.

The Company had working capital in the amount of $1,041,407 at September 30, 2008. Included in our working capital is $280,561 of short term notes receivable and $50,000 in investments in marketable securities.

Our cash flows for the periods are summarized below:

  Nine Months Ended Nine Months Ended 
  September 30, 2008 September 30, 2007 
      
Net cash provided by (used in) operating activities 
$
(71,847
)
$
961,522
 
Net cash provided by (used in) investing activities $(147,391)$613,799 
Net cash provided by (used in) financing activities $(47,606)$1,054,787 

Our cash has decreased by $245,527 since December 31, 2007.

Management believes the Company has adequate working capital and cash to be provided from operating activities to fund current levels of operations. We anticipate that our company will grow. As our business grows we believe that we will have to raise additional capital in the private debt and public equity markets to fund our investments.


18

Off-Balance Sheet Arrangements
The Company leases administrative office space in Houston, Texas at a current minimum annual cost of $74,032. The Company is also responsible for its share of property tax, maintenance and utility costs on the office building lease. The lease expires in January 2010.

INII leases its building and warehouse in Ottawa, Canada at a current minimum annual cost of $308,230. The Company is also responsible for its share of property tax, maintenance and utility costs on the warehouse lease. The leases expire on April 30, 2009.
Future minimum payments under the office, building and warehouse leases described above, on a fiscal year basis are as follows:
2008 $96,373 
2009  177,852 
2010  6,169 
  $280,394 
Inflation
The Company believes that inflation has not had a significant impact on operations since inception.

19

ITEM 4T. CONTROLS AND PROCEDURES
(A) Evaluation of Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, accumulated and communicated to the Company’s management, including its Chief Executive Officer ("CEO") who also serves as the Company’s Interim Chief Financial Officer ("CFO"), as appropriate, to allow timely decisions regarding required disclosure.
As of the end of the period covered by this report, the Company's management carried out an evaluation, under the supervision and with the participation of the Company's CEO and CFO (one individual), of the effectiveness of the design and operation of the Company's system of disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the material weaknesses described herein, the Company's CEO and CFO (one individual) has concluded that the Company's disclosure controls and procedures were not effective, as of the date of that evaluation, for the purposes of recording, processing, summarizing and timely reporting of material information required to be disclosed in reports filed by the Company under the Exchange Act.

Because of its size, the Company shares its accounting staff with another company located in the same suite in Houston, Texas and is comprised of its controller and a data entry clerk. The controller and data entry clerk are considered contract employees whom also work for the other company within the office suite as contract employees. We currently do not have the resources to hire full-time accounting personnel and do not anticipate hiring any full-time accounting personnel in the near future. Because of the structure of our staff, we have a failure to maintain effective controls over the selection, application and monitoring of our accounting policies to assure that certain complex equity transactions are accounted for in accordance with generally accepted accounting principles.

Material Weaknesses Identified
In connection with the audit of our Consolidated Financial Statements for the fiscal year ended December 31, 2007, our independent registered public accounting firm informed us that we had significant deficiencies constituting material weaknesses as defined by the standards of the Public Company Accounting Oversight Board, which had been identified in connection with the audit of our Consolidated Financial Statements for the fiscal years ended December 31, 2007.

The material weaknesses identified by the auditor during the December 31, 2007 audit were the lack of segregation of duties necessary to maintain proper checks and balances between functions and the lack of procedures to properly account for non-routine transactions including the write down of stock investment, impairment of an investment in a partnership and recording of the additional liability at the liquidation value for a series of preferred stock which was to be completely liquidated at December 31, 2007.

The absence of qualified full time accounting personnel was a contributing factor to the problems identified by the auditor. The specific circumstances giving rise to the weaknesses include utilizing the services of contract accountants on a part time basis in the absence of internal accounting personnel.

(B) Changesin Internal Controls over Financial Reporting
In connection with the evaluation of the Company's internal controls during the Company's last fiscal quarter covered by this report required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, the Company's CEO and CFO (one individual) has determined that there were no changes to the Company's internal controls over financial reporting that have materially affected, or are reasonably likely to materially effect, the Company's internal controls over financial reporting.
20

PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS

None

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide information under thi Item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None.
ITEM 6. EXHIBITS
(a) Exhibits:
EXHIBIT NO.
DESCRIPTION
LOCATION
3.1 and 3.2AppTechCorp.Articlesof Incorporation and Conversion of Natural Nutrition, Inc.Incorporated by reference to Exhibits 3.1 andfiled October 25,2006(filed as Exhibit 3.2 to the Company’sRegistrant’s Annual Report on Form 10-KSB10-K, as filed with the Securitieson March 30, 2020, and Exchange Commission on April 13, 2007incorporated herein by reference)
 
3.3AppTechCorp.Certificateof Designation filedMay 09, 2007(filed as Exhibit 3.3 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.4AppTechCorp.Certificateof CorrectionfiledJune 04, 2007 (filed as Exhibit 3.4 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.5AppTechCorp.Certificateof Designation filed June06, 2007(filed as Exhibit 3.5 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.6AppTechCorp.Amendment to Certificateof DesignationAfterIssuanceof ClassorSeriesfiledNovember 17, 2008 (filed as Exhibit 3.6 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.7AppTechCorp.Certificateof Amendment filed October 26,2009(filed as Exhibit 3.7 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.8AppTechCorp.Certificateof Amendment filed October 27,2009(filed as Exhibit 3.8 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.9AppTechCorp.Certificateof Designation filed April 21, 2010 (filed as Exhibit 3.9 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.10AppTechCorp.Amendment to Certificateof Designation After IssuanceofClassor Seriesfiled April 27, 2010 (filed as Exhibit 3.10 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.11AppTechCorp.Certificateof Change filed July 22, 2010 (filed as Exhibit 3.11 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.12AppTechCorp.Amendment to Certificateof DesignationAfterIssuanceof ClassorSeriesfiledOctober 26,2010(filed as Exhibit 3.12 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.13AppTechCorp.Amendment to Certificateof DesignationAfterIssuanceof ClassorSeriesfiledOctober 26,2010(filed as Exhibit 3.13 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.14AppTechCorp.Amendment to Certificateof DesignationAfterIssuanceof ClassorSeriesfiledOctober 28,2010(filed as Exhibit 3.14 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.15AppTechCorp.Amendment to Certificateof DesignationAfterIssuanceof ClassorSeriesfiled April 08, 2011 (filed as Exhibit 3.15 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)


3.16AppTech Corp. Certificate of Amendment filed June 06, 2011 (filed as Exhibit 3.16 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.17AppTech Corp. Articles of Domestication filed July 18, 2011 (filed as Exhibit 3.17 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.18AppTech Corp. Bylaws dated May 07, 2013 (filed as Exhibit 3.18 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.19AppTech Corp. Certificate of Domestication filed July 09, 2013 (filed as Exhibit 3.19 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.20AppTech Corp. Articles of Amendment filed October 31, 2013 (filed as Exhibit 3.20 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.21AppTech Corp. Certificate of Incorporation filed July 29, 2015 (filed as Exhibit 3.21 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
3.22AppTech Corp. Bylaws (Amended and Restated) dated March 27, 2020 (filed as Exhibit 3.22 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
4.1CSI Business Finance, Inc. 2006 StockAppTech Corp. Non-Employee Equity Incentive Plan.Incorporated by referencePlan dated March 27, 2020 (filed as Exhibit 4.1 to the Company's CurrentRegistrant’s Annual Report on Form 8-K10-K, as filed with the Securitieson March 30, 2020, and Exchange Commission on July 14, 2006.incorporated herein by reference)
10.1Purchase Agreement, dated effective December 31, 2007, by and among Natural Nutrition, Inc., CSI
4.2AppTech Code of Business Finance, Inc. and Corporate Strategies, Inc.Incorporated by referenceConduct (filed as Exhibit 109.14.2 to the Company's CurrentRegistrant’s Annual Report on 8-KForm 10-K, as filed with the U.S. Securitieson March 30, 2020, and Exchange Commission on January 3, 2008incorporated herein by reference)
10.2Amendment to Asset Purchase Agreement dated June 22, 2017 (filed as Exhibit 10.2 to the Registrant’s Annual Report on Form 10-K, as filed on March 30, 2020, and incorporated herein by reference)
10.5Lease & Purchase Option Agreement dated January 24, 2008, by and between Global Virtual Opportunities and Natural Nutrition, Inc.Incorporated by reference22, 2020 (filed as Exhibit 10.110.5 to the Company's CurrentRegistrant’s Annual Report on Form 8-K10-K, as filed with the U.S. Securitieson March 30, 2020, and Exchange Commission on February 1, 2008incorporated herein by reference)
31.1Certificate pursuant to 15 U.S.C. Section 7241, as adopted pursuant toCertification of the Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002 dated May 14, 2020
Provided herein
31.2Certification of the Chief Financial Officer under Section 302 of the Sarbanes-Oxley Act of 2002 dated May 14, 2020
32.1Certificate pursuant to 18 U.S.C. Section 1350, as adopted pursuant toCertification of the Chief Executive Officer under Section 906 of the Sarbanes-Oxley Act of 2002Provided herein
21


SIGNATURES dated May 14, 2020
In accordance with the requirements of the Exchange Act, the Company has caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.
 Date: November 13, 2008Natural Nutrition, Inc.
(Registrant)
  
32.2 /s/ Timothy J Connolly


Signatures

Pursuant to the requirements ofthe Securities andExchangeAct of 1934, theregistranthasduly causedthisreport to be signed onits behalf bythe undersigned thereunto dulyauthorized.

AppTech Corp.
  
Date: May 14, 2020By:/s/ Luke D’Angelo
Luke D’Angelo
Interim Chief Executive Officer and Chairman
Date: May 14, 2020By:/s/ Gary Wachs
Gary Wachs
Chief Financial Officer

28

 
22